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Chapter 1 
INTRODUCTION 

IntToductjoii 11 
1.1 Neurogenic Urogenital Tract Dysfunction 
Neurological disease is often associated with dysfunction of the urogenital tract, and 
vice versa. Many patients with neurological disease or metabolic disorders causing 
neuropathy present with voiding difficulties, urinary incontinence or erectile 
dysfunction. In patients with multiple sclerosis the incidence of complaints of urinary 
tract dysfunction varies from SO1 to 97 per cent2. In patients with diabetes mellitus 
erectile dysfunction has been reported in 25 per cent at the age of 30 years, and in 
54 per cent in diabetic males over 50 years of age.3 
Medical status often associated with neurogenic urogenital tract dysfunction is listed 
in table 1. 
Table 1: Factors associated with neurogenic urogenital trad dysfunction 
neurological disease multiple sclerosis 
Parkinson disease 
traumatic cord lesion 
herniated disc 
(occult) spinal dysraphism 
spinal tethered cord 
pelvic nerve damage proctocolectomy 
radical prostatectomy 
vaginal childbirth 
hysterectomy 
irradiation therapy 
trauma 
metabolic disease diabetes mellitus 
alcohol abuse 
renal failure 
During the past two decades concepts and understanding of neurogenic urogenital 
tract dysfunction have undergone important changes. Until the early 1970s the mere 
history of neurological disease, surgical intervention in the small pelvis or metabolic 
disturbances in a patient with complaints of urogenital tract dysfunction sufficed for 
the conclusion of the dysfunction being neurogenic. The introduction of sophisticated 
neurophysiological investigatory techniques paved way for more precise and detailed 
neurological evaluation of the functional status of the urogenital tract. 
These newly developed techniques only partly confirmed the old pathophysiological 
concepts: neurophysiological investigations proved not only to be normal in patients 
with obvious neurological disease, thus underlining the importance of a multi-causal 
and multi-disciplinary approach, but also detected clear abnormalities in unsuspected 
patients. The latter finding gave new insight in pathophysiology of urogenital tract 
dysfunction. These studies also underlined the lack of correlation between subjective 
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complaints and the outcome of objective tests. Therefore, the importance of reliable 
and practicable investigatory techniques for the evaluation of neurogenic urogenital 
tract dysfunction is beyond any doubt. 
Methods currently available for objective evaluation of (neurogenic) urogenital tract 
dysfunction are urodynamic investigations (for example urethral pressure 
profilometry, cystometry and pressure-flow studies) as recommended by the 
Standardization Committee of the International Continence Society4, video 
micturition cysto-urethrography5 and neurophysiological investigations. Current status 
and latest developments of the latter are the subject of this thesis. 
1.2 Historical Review 
1.2.1 Electromyography (EMG) and Nerve Conduction Velocity 
The first report on the electrical activity produced by muscular contraction was by 
Galvani in 1791. The first to use this electric activity for clinical purposes was 
Wertheim-Salomonson in 1920, but the introduction of the concentric needle 
electrode by Adrian and Bronk in 1929 must be considered as the real breakthrough 
of clinical electromyography.6 This enabled artifact free EMG registration in 
humans, and thus lead to the discovery of electromyographic features 
pathognomonic for neuro-muscular disease (for example fibrillation potentials). Also 
the introduction of nerve conduction velocity measurement must be considered as a 
milestone for clinical neurophysiology. What was begun by Dawson and Scott in 
1949, for clinical neuro-urology lead in the early 1970s to the introduction of the 
sacral reflex-arc latency measured in the anal sphincter after electrical stimulation of 
the pudendal and pelvic nerves by Bradley.7,8 Galloway called these sacral reflexes 
quite striking "the Urologist's Knee Jerk".9 
1.2.2 Cortical Evoked Potentials 
Caton in 1875 was the first to report on the recording of spontaneous electrical 
activity of the brain of rabbit and monkey.10 For his experiments he used a simple 
galvanometer. Berger recorded the human electroencephalogram some 50 years 
later.11 He observed clear changes in the spontaneous activity of the brain on 
sensory stimulation.12 For clinical practice, however, the use of these stimulus 
induced changes was limited. In 1944 Adrian wrote 'with present methods the skull 
and scalp are too much in the way, and we need some new physical method to read 
through them'.13 Dawson's technique of photographic superimposition14 met with 
Adrian's demands and set stage for the technique of averaging of cortical evoked 
potentials after stimulation of peripheral sensory nerves.15·16 The essence of this 
method of averaging was that it demands an accurate time-locked record obtained 
by triggering the oscilloscope sweep from the stimulus. Dawson showed that the 
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short latency response evoked by stimulation of a peripheral sensory nerve was 
localized over the primary receiving area in the contralateral Rolandic cortex and 
thus followed the known representation of the contralateral side of the body in the 
sensory cortex. Dawson's method had the great advantage that it made very small 
potentials accessible for evaluation, but it had the major drawback of demanding 
stimulus-locked recording of a large number of responses.17 A real breakthrough for 
this technique of evokation and registration of cortical evoked potentials was of a 
more recent date: The explosive progress in the field of computer technology 
providing excellent calculating and data-storage facilities enabled quick and accurate 
measurement of electrical cortical activity induced by repetitive activation of somato-
sensory nerves. In urology, this has lead in 1982 to the introduction of the 
measurement of a cortical evoked potential after electrical stimulation of the 
pudendal nerve by Haldeman and co-workers.18 
A review of the literature on the methodology and application in clinical urological 
practice of these neurophysiological tests will be given in chapter 2. 
1.3 Neuro-anatomy of the Urogenital Tract 
Neuro-anatomy of the urogenital tract can be described by the distinction between 
central areas and tracts, and peripheral nerves. Within these central and peripheral 
neural tracts distinction can be made between autonomic and somatic tracts. 
Functionally these autonomic and somatic tracts are closely related. From a neuro-
anatomical viewpoint, however, they are clearly distinguishable and separable. The 
urogenital tract is one functional unity in the human body where direct interaction 
and communication between the autonomic and somatic nervous system is especially 
important. Reciprocal facilitation and inhibition of central autonomic and somatic 
nuclei by peripheral and central neurons is a prerequisite for micturition and urine 
storage as well as penile erection. Because of this, neurophysiological diagnostic 
techniques focus on these autonomic and somatic centers and nerves. 
13.1 Neuro-Anatomy related to Micturition and Urine Storage 
Areas involved with micturition are located in the central vertex of the skull anterior 
(motor) and posterior (sensory) to the central gyrus.19,20,21 More centrally the 
thalamus plays an important role as a relais station for autonomic and somatic 
sensory and motor impulses to and from the bladder. The limbic system as well as 
the basal ganglia have modulatory influences on detrusor muscle and urethral 
sphincter functions.22 In the brainstem, motor and sensory cell populations are found 
with facilitative influences on bladder contraction.23,24 The fastigial nuclei of the 
cerebellum play an important coordinatory role in the processes responsible for 
micturition and urinary continence. These nuclei coordinate increment of pelvic floor 
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muscle tone with increasing bladder volume as well as suppression of detrusor 
contractions in the storage phase; in the micturition phase the cerebellar nuclei 
regulate pelvic floor relaxation and subsequent bladder contraction. Spinal pathways 
from and to detrusor and pelvic floor muscle nuclei consist of ascending (sensory) 
and descending (motor) tracts.25,26 These pathways connect with the autonomic 
detrusor nucleus and somatic pelvic floor nucleus, whose cell clusters are 
concentrated in the sacral segments of SI to S4.27·28 Peripherally autonomic motor 
and sensory innervation of the detrusor muscle and bladder mucosa is through the 
parasympathetic nerves arising from the sacral segments and through sympathetic 
nerves descending from the thoraco-lumbar region via the hypogastric nerves.29 Both 
parasympathetic and sympathetic nerves meet in the pelvic plexus which innervates 
the detrusor muscle, the bladder trigone, the mucosa and smooth musculature of the 
urethra and prostate gland.30,31 Peripheral innervation of the pelvic floor muscles is 
through the somatic pudendal nerves.32 
A functional description of lower urinary tract innervation is best done by the loop-
concept introduced by Bradley.22 Loop I are the connections between brainstem, 
thalamus and basal ganglia and the frontal cerebrocortical areas. Loop II are the 
ascending and descending pathways between the brainstem and the urinary bladder. 
This loop includes autonomic spinal tracts and sacral nuclei. The peripheral part of 
loop II is constituted by the motor and sensory parasympathetic nerves of the pelvic 
plexus. Loop III is formed by sacral autonomic and somatic sensory and motor 
nerves, the sacral autonomic and somatic centers as well as the interneurons that 
interconnect these centers. Loop III represents the autonomic and somatic reflex 
arcs. Loop IV concerns sacral and suprasacral nuclei and tracts involved with 
pudendal motor nerve action. It includes areas in the central motor cortex, 
pyramidal tracts, sacral motor neurons and the pudendal nerves. 
1.3.2 Neuro-Anatomy related to Penile Erection 
Neurophysiological processes responsible for obtaining and maintaining penile 
erection originate in the central nervous system through integration of sexual stimuli 
(for example tactile, audio-visual, gustatory and olfactory) and through mechanical 
and reflexogenic stimuli to the genital organs.33,34 In the brain the hypothalamus and 
the limbic system play a key role in erection.35 From there efferent pathways travel 
via the median forebrain bundle to the substantia nigra, the pons and medulla. In 
animal studies hypothalamic projections travelling through the lateral funiculus and 
terminating in the thoracolumbar sympathetic, the lumbosacral parasympathetic and 
sacral somatic centers have been proved. Sympathetic preganglionic fibres to the 
penis arise from the intermediolateral grey matter from the 11th thoracic to the 2nd 
lumbar spinal cord segments.36 Sympathetic nerve Fibres pass from the ventral roots 
via the white rami to the paravertebral sympathetic chain ganglia. More distally 
these nerve fibres intermingle with pelvic, cavernous and pudendal nerves. More 
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rostrally preganglionic fíbres travel to the prevertebral ganglia to form the superior 
hypogastric plexus from whereon postganglionic fibres interconnect as hypogastnc 
nerves with the pelvic parasympathetic nerves to form the pelvic plexus. Thus, this 
pelvic plexus is an important site for integration of input into the penis. 
The most important parasympathetic efferent nerves arise from the S2 to S4 sacral 
spinal cord segments. As nervi erigentes they travel along the pelvic plexus and 
enter the penis as the cavernous nerves.37,38 
The autonomic lumbosacral centers are localized in the intermediolateral nucleus, 
that contains the parasympathetic preganglionic neurons of the pelvic nerves and 
receives it's afferent inflow through interneuronal projection from the medial dorsal 
horn and dorsal commissure.39 These regions on their turn are activated by somatic 
afférents of the dorsal penile nerve. Hence, the dorsal penile nerve plays an 
important role in the reflex activation of penile erection.40 The somatic lumbosacral 
centers are concentrated in the ventral horns of the segments S2 and S3 (Onufs 
nucleus).41 Herein lay the motor neurons of the pudendal nerves that innervate the 
pelvic floor and levator muscles. The latter are of contributory importance for penile 
erection.42,43 
1.4 Neuro-Urophysiological Investigations (NUPHI) 
Since 1988 for the evaluation of neurogenic dysfunction of the urogenital tract we 
use a combination of tests as proposed by Anten et al.44 This consists of the 
measurement of the latency of the Tibial Evoked Potential (ТЕР), Pudendal Evoked 
Potential (PEP), Bulbocavernosus Reflex (BCR) and Urethro-Anal Reflex (UAR). 
For the combination of these four tests the term "Neuro-Urophysiological 
Investigation (NUPHI)" was introduced. Neurophysiological backgrounds and aspects 
concerning technical conduction of these measurements will be described below. 
1.4.1 General Considerations 
Neuro-urophysiological investigations are carried out using a commercially available 
stimulation and registration apparatus (Nicolet Compact-4, Nicolet Pathfinder). 
During the whole investigation the patients are in the supine position, in a room 
with a constant temperature of 25 °C. Before starting the preparations for the tests 
and doing the actual measurements the patients are extensively informed about the 
objectives of the procedure as well as the nature and severity of the burden that 
may be caused by electrical stimulation of nerves, insertion of an indwelling catheter 
and electromyography needle. It is our experience that clear explanation of the 
method together with a supportive and understanding approach adds to the success 
of the procedure. 
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The preparations for the actual measurements consist of cleaning the skin on those 
locations on the skull where the registrating electrodes will be attached. For this 
purpose a special abrasive (OmniPrep) is used. Following the 10-20 EEG system 
(figure 1) silver plated cup-electrodes are placed on the loci Cz-2 (2 cm behind Cz; 
active electrode), Fpz (passive electrode) and Fz (grounding electrode). The 
electrodes are fixed with EEG-Sol (Meditrace) that can easily be removed after the 
procedure with a moistened swab. Electrode resistance is kept below 1.5 kn. 
Figure 1: Electrode sites via the 10-20 EEG system45 
Furthermore, a balloon catheter (МТС-Medical) with two ring electrodes 10 and 20 
mm from the base of the balloon is inserted into the bladder. After insertion into 
the bladder and filling of the balloon the catheter is retracted, allowing for direct 
electrical stimulation of the mucosa of the proximal urethra. 
Also a concentric needle electrode (Dantec) is placed in the right ventral quadrant 
of the external anal sphincter muscle for registration of electromyographic activity at 
rest and at voluntary contraction, and for measurement of bulbocavernosus reflex 
and urethro-anal reflex latency. We use needle electrodes instead of surface 
electrodes because the former allow for analysis of electromyographic signs of 
denervation, such as fibrillation potentials, positive sharp waves and polyphasic 
potentials. The use of needle electrodes for sacral reflex latency measurements is 
also favoured because of technical advantages.46 
Preparation of the patient is completed by wrapping a self adhesive strap grounding 
electrode soaked in saline around the right upper thigh. 
For distinction between "normal" and "abnormal" neuro-urophysiological test results 
we use normal values gathered in 86 healthy volunteers (50 males, 36 females).47 
The finding in an individual patient of a latency above the normal range is 
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considered "abnormal". Non-evokability in somatosensory evoked potential or sacral 
reflex latency measurement is also considered pathological, because this 
phenomenon was never seen in the healthy volunteers. Reference values are given 
in table 2. 
Table 2: Reference values 
Response normal range 
(mean ± 2SD) 
tibial evoked potential (ТЕР) 35 - 46 ms 
pudendal evoked potential (PEP) 36 - 47 ms 
bulbocavcmosus reflex (BCR) 20 - 40 ms 
urelhro-anal reflex (UAR) 46 - 75 ms 
1.4.2 Tibial Evoked Potential (ТЕР) 
The tibial evoked potential reflects the sensory tract whose fibres run from the 
medial malleolus of the ankle through the tibial and ischiadic nerves and enter the 
sacral conus at the level L5-S1. From thereon the sensory input is transmitted to the 
sensory cortex through the dorsal columns, brain stem and thalamus. The 
representative cortical cell populations lay superficial in the midline interhemispheric 
fissure 2 cm behind the central gyrus; this locus corresponds with Сг-2. 
The tibial evoked potential is obtained with bipolar percutaneous stimulation of the 
tibial nerve at the ankle of the foot, with the cathode proximal to the anode. The 
tibial nerve is mixed in nature (motor and sensory); therefore, stimulus intensity is 
considered accurate if a clear motor response (that is rhythmic plantar flexion of the 
toes) is visible. We apply two consecutive series of approximately two-hundred 
stimuli; stimulus duration is 0.2 ms with a random stimulus frequency of 
approximately 2.7 Hz. The evoked potential is recorded with silver plated cup 
electrodes from the Cz-2 point. We average 200 stimuli with a high frequency filter 
setting at 1500 Hz and a low frequency filter setting at 50 Hz. Amplifier sensitivity 
is 100 μΥ. Latency time is defined as P, at the first positive (downward) deflection 
of an averaged curve. All curves are measured twice to check repeatability. Curves 
in which the cortical response can not be identified are classified as "non-evokable". 
1.4.3 Pudendal Evoked Potential (PEP) 
The pudendal evoked potential reflects the sensory tract whose fibres run from the 
dorsum of the penile shaft or clitoris through the dorsal penile or clitoral nerves and 
onwards through the pudendal nerves; they enter the sacral conus at the level S2-S4. 
From thereon the sensory input is transmitted to the sensory cortex through the 
dorsal columns, brain stem and thalamus. The representative cortical cell 
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populations lay deep in the midline interhemispheric fissure 2 cm behind the central 
gyrus (Cz-2). 
Because of the specific neuro-anatomic differences (that is the differences in length 
and constitution of the peripheral part of the evoked potential, and the differences 
in level of entrance of the peripheral nerve into the spinal cord), combination of 
tibial evoked potential and pudendal evoked potential measurement allows not only 
for the differentiation of peripheral and central neuropathies but also for 
discriminating between sacral (S2-S4) and supra-sacral neural tract affliction. 
Technical conduction of pudendal evoked potential measurement is similar to tibial 
evoked potential, with the obvious exception of the different stimulation site. For 
pudendal evoked potential measurement stimulus intensity is considered adequate if 
it is at least twice the sensory threshold, which is defined as the lowest current 
perceptible at the penile shaft or clitoris. 
1.4.4 Bulbocavemosus Reflex (BCR) 
Bulbocavernosus reflex reflects a somatic reflex arc. It's afferent input travels from 
sensory nerve endings in the skin of the penile shaft through the dorsal penile 
nerves and pudendal nerves that enter the sacral conus at the segments S2 to S4. 
Via the sacral interneurons and the motor neurons in Onufs nucleus the efferent 
output travels through pudendal nerves that innervate the bulbocavemosus and 
ischiocavernosus muscles as well as the external anal sphincter muscles. 
To measure bulbocavernosus reflex latency, penile stimulation is done on the penile 
shaft using single shocks. Recording is in the right ventral quadrant of the external 
anal sphincter muscle with a concentric needle electrode (Dantec). Eight separate 
latency measurements are recorded using supramaximal square-wave stimuli of 60 
mA (stimulus duration, 0.2 ms). Thus, consistent and repeatable measurements are 
obtained. If bulbocavernosus reflex measurement reveals a delayed or absent 
response, the EMG-needle is reinserted into the left ventral quadrant and the 
recording is repeated. In that case shortest latency is used for further evaluation. 
For our studies only those bulbocavernosus reflex measurements are considered 
"abnormal" in which repeated recordings give delayed or non-evokable responses. 
1.4.5 Urethro-Anal Reflex (UAR) 
Urethro-anal reflex reflects a combined autonomic and somatic reflex arc. It's 
afferent fibres consist of sensory nerve fibres in the urethral mucosa which travel 
centrally through autonomic pelvic nerves that enter the sacral conus mainly at the 
level of S2 to S4. Sacral interneurons activate somatic motor neurons (Onufs 
nucleus) of the pudendal nerves. The efferent part of the urethro-anal reflex is the 
same as for bulbocavernosus reflex, that is the pudendal nerves that innervate the 
bulbocavemosus and ischiocavernosus muscles as well as the external anal sphincter 
muscles. 
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Technical conduction of urethro-anal reflex latency measurement is similar to 
bulbocavernosus reflex, with the exception of the different stimulus site, that is the 
mucosa of the bladder neck. Because of the different sensoiy innervation of the 
bladder neck urethro-anal reflex reflects autonomic sensoiy nerve function. To 
stimulate the bladder neck the above mentioned balloon catheter with bi-polar 
stimulation electrodes is used. Again recording is in the right ventral quadrant of the 
external anal sphincter muscle; eight separate latency measurements are recorded 
using supramaximal square-wave stimuli of 60 mA (stimulus duration, 0.2 ms). As is 
the case for bulbocavernosus reflex measurement, consistent and repeatable 
measurements are obtained. If urethro-anal reflex measurement reveals a delayed or 
absent response, the EMG-needle is reinserted into the left ventral quadrant and 
the recording is repeated, and shortest latency is used for further evaluation. For 
this study only those urethro-anal reflex measurements are considered "abnormal" in 
which repeated recordings give delayed or non-evokable responses. 
Neuro-urophysiological measurements and neuro-anatomical pathways are depicted 
in figure 2. 
1.4.6 Urethral Sensoiy Threshold 
Additional to the above described neuro-urophysiological investigations in some 
patients we measure the urethral sensoiy threshold using the aforementioned 
electrodes mounted on the balloon catheter. The urethral sensory threshold is 
defined as the lowest level (in mA) at which a patient can feel the square-wave 
pulses (stimulus duration, 0.2 ms; frequency, 1.3 Hz) applied through the catheter-
mounted electrodes as a throbbing or burning sensation. This measurement is 
repeated three times, taking the lowest value as the sensoiy threshold. 
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Figure 2: Neuro-urophysiological Investigations (NUPHI) 
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Chapter 2 
REVIEW OF THE LITERATURE 
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2.1 Neurophysiological Tests in Urology 
The first report in urological literature on the use of neurophysiological tests for the 
determination of neurologically mediated urogenital tract dysfunction was by 
Rushworth in 1967,1 followed by papers by Bradley and co-workers in the early 
1970s.2,3 They describe the equivalents of bulbocavernosus reflex and urethro-anal 
reflex latency measurements. For both measurements they report latencies similar to 
those listed in table 2 (chapter 1.4.1). An important conclusion of their studies is 
that because of the differences in latency of bulbocavernosus reflex and urethro-anal 
reflex both measurements reflect distinct parts of urogenital tract innervation as 
discussed in chapters 1.4.4 and 1.4.5. They suggest the use of the combination of the 
two tests for mapping of urogenital reflex arcs and localization of lesions. Important 
is their statement that neurophysiological tests like bulbocavernosus reflex and 
urethro-anal reflex are able to demonstrate minor neurological defects long before 
clinical signs of neuropathy occur. Therefore, Jelasic et al prefer such tests above 
clinical investigations.4 They use a somewhat different technique of direct stimulation 
of pudendal motor fibres through the sacral foramina and registration of the 
response in the anal sphincter. The latter technique has also been used later on by 
Swash and Snooks.5 Ertekin and Reel are the first to use bulbocavernosus reflex 
measurement in selected patients with neurogenic bladder dysfunction and 
impotence.6 They find good correlation between the neurological substrate and the 
outcome of the bulbocavernosus reflex test. Clinical application of bulbocavernosus 
reflex and urethro-anal reflex measurements has been further elaborated by 
Rockswold and Bradley, Yalla, Siroky, and Blaivas et al.7·8,9,10 All of these early 
studies confirm the usefulness of these tests for the evaluation of the functional 
status of sacral urogenital tract innervation. They also stress the superiority of such 
tests to clinical investigations. 
Measurement and analysis of sacral reflex responses has also been used for 
improving the understanding of the underlying physiology of such responses. Krane 
and Siroky, Vereecken as well as Vodusek et al conclude from their observations 
that the bulbocavernosus reflex is a non-habituating oligosynaptic reflex.11,1Z'13 Apart 
from indicating possible interpretation pitfalls they also stress the usefulness for 
clinical practice. Possible pitfalls are the dependency of the induced signal on the 
stimulus intensity and duration. Therefore, supramaximal stimuli should be applied. 
Another problem is the implication of an absent response to an adequate stimulus. 
This might be due to inaccurate needle placement, or to the fact that a response is 
precluded by the resting firing activity of the muscles under investigation, or to 
voluntary suppression. 
First reports on the use of somatosensory evoked potentials of the urogenital tract 
are in the early eighties. Haldeman et al compare morphologic features, peak 
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latencies, and peripheral and central conduction times of tibial evoked potential and 
pudendal evoked potential.14 They found that total conduction time is very similar 
for tibial evoked potential and pudendal evoked potential although travelling 
distance for the pudendal evoked potential is half that of the tibial evoked potential. 
From this finding they conclude that conduction velocity (peripheral as well as 
central) is much slower in pudendal evoked potential compared to tibial evoked 
potential. Physiologically this difference is explained by the fact that tibial nerves 
contain very rapid conduction proprioceptive afférents whereas the pudendal nerves 
contain only cutaneous afférents, which conduct more slowly, both peripheral and 
central. They conclude that sensitivity and clinical value of neurophysiological 
techniques will be determined by the results of testing of symptomatic patients. 
Opsomer et al determined reference values for pudendal evoked potential in healthy 
volunteers.15 Their findings are well in accordance with ours as given in table 2 
(chapter 1.4.1). They conclude that pudendal evoked potential latency is 
reproducible within narrow ranges. 
Neurophysiological methods for the evaluation of bladder and urethral sensibility 
have been described and clinically applied by Frimodt-Müller, Kiesswetter, and 
Powell and Feneley.16,17,18 These authors found that the technique is reliable and 
repeatable and that the outcome correlates well with clinical neuro-urological status 
(for example diabetes mellitus, Parkinson's disease, spina bifida). They also mention 
good correlation between sensory thresholds evaluated by electrical stimulation and 
bladder sensitivity evaluated by cystometry (that is first desire to void). Some types 
of bladder dysfunction were accompanied by typical sensory disturbances. Frimodt-
Möller states that electrostimulation is superior to thermal stimulation in 
differentiating between sensory qualities, because the latter is said to be non-specific 
and hard to quantify. These authors stress the importance of sensory nerves in 
urogenital tract physiology. 
Measurement of cortical evoked potentials after stimulation of the bladder and 
urethra has met some advocates in the past. Mono-polar as well as bi-polar 
stimulation techniques have been used.19'20,21,22,23 These reports try to deal with 
difficulties with the stimulation procedure and technical problems with recording the 
evoked potentials. Mono-polar stimulation yields unequivocal responses with the 
restriction that most probably remote somato-sensory nerves are stimulated at the 
site of the reference electrode. Bi-polar stimulation on the other hand diminishes 
the amplitude of the response in such a way that interpretation of the averaged 
responses becomes more a matter of estimation rather than of measurement. In the 
early 1980s this technique was introduced as being very promising, although already 
at that time it was clear that technical improvement still was needed. One of the 
major drawbacks is that none of the authors succeeded in recording a clear and 
reproducible positivity (P,) on bi-polar stimulation of the bladder and urethra. It is 
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our own observation that a cortical evoked response from the proximal urethra 
could be measured in approximately SO per cent of a group of volunteers (own 
observations, unpublished data). To date, therefore, this technique seems to play a 
minor role in clinical neurophysiological testing of patients with urogenital tract 
dysfunction. 
Another neurophysiological technique subject to much debate is the recording of a 
"bladder electromyogram". In 1951 Corey reported the recording of bladder electro-
myograms using bi-polar surface electrodes.24 A similar report by Boyce in 1952 was 
discarded by Brunsting as "artifact" due to bladder motility.25,26 Recently Doyle and 
co-workers admit the technical difficulties, even when well fixed hooked-wire 
electrodes are used; more bothersome, however, is their finding of lack of 
correlation between electromyographic changes in the detrusor muscle and intra­
vesical pressure alterations. The most recent paper on bladder electromyography 
reports on the use of catheter mounted carbon fibre surface electrodes.27 It shows a 
good correlation between bladder pressures and electromyographical activity. 
However, the authors keep silent about the technical limitations of surface 
electrodes, and appear to have measured artifacts. 
A neurophysiological technique that also failed to gain widespread clinical use is the 
measurement of penile dorsal nerve conduction velocity.28,29 The glans penis is 
stimulated electrically and the response is measured at the base of the stretched 
penis. Nerve conduction velocity is calculated by dividing the conduction time by the 
length of the penile shaft. This technique is quite impracticable in a small penis, and 
its results are dependent on the conduction and calculation methods used. No report 
exists that has investigated the superiority of this difficult technique to 
bulbocavernosus reflex measurement. 
The latest addition to the neumurological diagnostic armamentarium is the 
registration of electromyographic activity of the smooth musculature of the penile 
corpora cavernosa ("penis-EMG"). This technique was warmly welcomed because it 
provides information about urogenital motor pathways, whereas existing techniques 
yield information on the functional status of urogenital sensoiy pathways only. Since 
"bladder-EMG" has been abandoned because of technical and methodological 
inadequacies, "penis-EMG" might fulfil the demands of its unsuccessful predecessor. 
This new technique to evaluate the autonomic motor innervation of the urogenital 
tract has been initiated by Gerstenberg and Wagner: By means of a needle 
electrode introduced in the cavernous body, a baseline intermittent firing activity is 
recorded.30,31 After audio-visual sexual- and/or pharmacological stimulation with 
increasing tumescence and rigidity a decrease of cavernous smooth muscle activity is 
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noted. Only recently, single potential analysis of cavernous electric activity (SPACE) 
has been introduced in the diagnosis of cavernous autonomic neuropathy and 
cavernous smooth muscle dysfunction.32 Specific types of potentials are observed in 
impotent patients with upper motor neuron or peripheral lesions. 
A very promising technique for the investigation of the somatomotor mnervation of 
the urogenital tract is the evokation of motor evoked potentials derived from the 
pelvic floor muscles on magnetic stimulation of the cerebral cortex and the cauda 
equina. Several authors have used this technique of magnetic stimulation for 
investigation of the pelvic floor muscles.33,34 They report on artifact free registrations 
of central and peripheral motor conduction times, that are well within physiological 
margins. 
22 Neurophysiological Tests in Clinical Urologica! Practice 
2.2.1 Erectile Dysfunction 
In a review article on the current state of the art of diagnosis and treatment of 
erectile dysfunction, Krane et al confine the diagnosis of neurogenic erectile 
dysfunction to patients with a known neurologic disorder.35 They recommend 
physical examination and neurophysiological testing as most suitable for establishing 
the correct diagnosis. As a first choice neurophysiological test they use penile 
biothesiometry to measure sensory perception to vibratory stimulation. Furthermore, 
they consider bulbocavernosus reflex and pudenda] evoked potential testing useful 
for the determination of peripheral, sacrospinal, and central neurological pathology. 
Wabrek conducted bulbocavernosus reflex measurements in 100 consecutive cases of 
erectile dysfunction.36 He found abnormal test results in 9 per cent of the patients. 
Noteworthy is his conclusion that success of therapeutic options such as sex therapy 
and penile revascularization is questionable in those patients with impairment of the 
sexual neurological mechanism as proved by an abnormal bulbocavernosus reflex. 
Therefore, he recommends such investigation before even considering these 
therapeutic interventions. 
Ertekin et al investigated 97 patients with complaints of erectile dysfunction and 
various kinds of concomitant disease such as diabetes mellitus, spinal cord injury, 
Parkinson disease and multiple sclerosis.37 They report good correlation between the 
neurological substrate and the outcome of somatosensory evoked potential 
measurements after stimulation of the peroneal nerve (equivalent of tibial evoked 
potential) and dorsal penile nerve (pudendal evoked potential) and bulbocavernosus 
reflex measurements. They advocate the use of these tests to support the diagnosis 
of psychogenic impotence. 
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Tackmann et al conducted pudendal evoked potential measurements in 145 patients 
with erectile dysfunction of various origin, and in 30 healthy volunteers.38 They 
prove that pudendal evoked potential latency is related to body height in healthy 
volunteers. Compared with the healthy volunteers they found abnormal pudendal 
evoked potentials in 40 out of 145 impotent patients (36 per cent). In a comparable 
study on 130 patients with erectile dysfunction this group of investigators found no 
less than 66 per cent of abnormalities using the combination of pudendal evoked 
potential and bulbocavernosus reflex.39 From this remarkable finding these authors 
conclude that the somatosensory innervation of the penis as tested by pudendal 
evoked potential and bulbocavernosus reflex must play an important role in the 
(patho)physiology of erectile dysfunction. 
Lavoisier et al performed the combination of nocturnal plethysmography and rigidity 
recordings with bulbocavernosus reflex measurements to determine the validity of 
the latter test.40 Of 19 impotent patients with abnormal bulbocavernosus reflex 
latencies 8 had normal nocturnal erections. They conclude that their findings cast 
some doubt on the validity of bulbocavernosus reflex measurement for the diagnosis 
of erectile dysfunction due to neurological disease. 
Nogueira et al performed comparable studies.41 Because of the finding of very few 
abnormalities on pudendal evoked potential and bulbocavernosus reflex testing, and 
because of the bad correlation between the neurophysiological parameters and the 
outcome of nocturnal tumescence and rigidity measurements they draw similar 
conclusions on the validity of pudendal evoked potential and bulbocavernosus reflex 
testing as Lavoisier et al. 
This brief review shows that the usefulness of neurophysiological tests for the 
evaluation of an organic factor in the etiology of erectile dysfunction is not yet 
unequivocally established. Especially the remarkable finding of abnormal 
neurophysiological tests in impotent men with normal nocturnal erections needs 
further clarification as will be done in chapter 5. 
2.22 Diabetes Mellitus 
In regard to erectile dysfunction neurophysiological tests have been frequently 
applied in impotent men with diabetes mellitus. This might be explained by the 
close relationship between diabetic neuropathy and impotence.42,43 In a study of 23 
normal men and 20 impotent diabetic men Lin and Bradley found no differences 
between the two groups for pudendal evoked potential and bulbocavernosus reflex 
measurement.44 The only significant difference they found was for the conduction 
velocity measurement of the dorsal nerve of the penis. They underline the 
importance of the penile sensory innervation for the (patho)physiology of erectile 
dysfunction, and they prefer this method of nerve conduction velocity measurement 
of the dorsal penile nerve to pudendal evoked potential and bulbocavernosus reflex 
testing. 
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Gallai and Mazzetta found a relation between the prolongation of bulbocavernosus 
reflex latency and duration of disease in a study of 63 impotent diabetics.45 Using 
bulbocavernosus reflex and urethro-anal reflex testing in 24 impotent diabetic men, 
Sarica and Karacan came to the interesting finding of normal bulbocavernosus reflex 
tests in almost all diabetics, whereas urethro-anal reflexes were abnormal in 66 per 
cent.46 They also found that an abnormal urethro-anal reflex correlated well with 
other signs of autonomic neuropathy, diabetes and organogenic impotence. They 
question the validity and clinical usefulness of bulbocavernosus reflex testing. 
Doubt on the usefulness of bulbocavernosus reflex and urethro-anal reflex testing is 
also casted by Fowler and by Desai et al.47,48 Their arguments are based on the 
finding of a poor correlation between the neuro-urophysiological tests and other 
parameters indicative for diabetic neuropathy. As an explanation for their findings 
they refer to earlier reports that state that sacral reflexes like bulbocavernosus reflex 
and urethro-anal reflex reflect neural pathways constituted by nerve Fibres relatively 
unsensitive to diabetic neuropathic damage. Hence, these tests are unsuited to 
detect such damage. 
2.2.3 Multiple Sclerosis 
Reports on neuro-urophysiological tests for the clinical evaluation of patients with 
multiple sclerosis are scarce. This can be explained by the fact that 
neuro(physio)logists underestimate the importance of urogenital tract dysfunction in 
these patients. Within the Kurtzke scale urogenital tract (dys)function is scored in 1 
system together with bowel (dys)function, and for this scale only subjective patients' 
complaints are used.49 This approach is all the more surprising since Goldstein et al 
have proved that in the long run in almost all patients with multiple sclerosis 
complaints of urogenital tract dysfunction are found, and that there is poor 
correlation between subjective complaints and objective abnormalities in these 
patients.50 The few neuro-urophysiological studies that do exist in patients with 
multiple sclerosis stress the usefulness of these tests for delineating the involvement 
of the urogenital tract innervation in the demyelinating process and for localization 
of occult sacral cord pathology.51 Kirkeby et al used pudendal evoked potential and 
bulbocavernosus reflex testing in 29 impotent men with multiple sclerosis. They 
found that these tests were more useful in defining neurogenic erectile dysfunction 
than nocturnal penile tumescence monitoring.52 
2.2.4 Spina] Dysraphism and Spinal Cord Injury 
Especially for the evaluation of urogenital tract dysfunction of unknown origin 
neuro-urophysiological testing might prove helpful. In cases where clinical 
neurological investigations fail to appoint an underlying neurological disease as the 
cause for urogenital tract dysfunction, such sensitive tests as mentioned above can 
do so. Fidas and co-workers have proved that in many cases of unexplained stress 
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urinary incontinence and adult nocturnal enuresis neuro-urophysiological tests show 
subtle abnormalities indicative for affliction of urogenital tract innervation.53,54 
Especially for the evaluation of spinal dysraphysm, of which the clinical and 
morphological manifestations can vary from "occult" (for example unexpected 
vertebral cleft revealed on a routine X-ray of the lumbo-sacral spine) to "manifest" 
(for example huge meningo-myelocele) an objective test seems to be very useful for 
mapping of the involvement of the sacral spinal cord. 
For the evaluation of patients with obvious neurological disease related urogenital 
tract dysfunction such as detrusor hypercontractility and incontinence in patients with 
complete traumatic transection of the cervico-lumbar spinal cord, neuro-
urophysiological tests seem to be of scientific value only.55 
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Aim of the Study 
Regarding the literature on the use of neurophysiological tests for clinical urologica! 
practice (Chapter 2) it is clear that this clinical field has only a short history yet. 
Literature is scarce and scattered over various techniques and methods. Several 
authors disagree upon the value of neurophysiological tests for urological practice 
because such tests put a great burden on the patients and yield results that do not 
contribute to the eventual clinical assessment. 
The aim of this thesis is to delineate the value of a combination of neuro-
physiological tests that together are called "Neuro-Urophysiological Investigations" 
(NUPHI, Chapter 1) for clinical urological practice. This thesis describes the 
possibilities and limitations of these Neuro-Urophysiological Investigations by 
applying the technique normal volunteers and in well defined patient groups such as 
patients with multiple sclerosis (chapter 4), erectile dysfunction and no signs of 
neurological disease (chapter 5) and erectile dysfunction and diabetes mellitus 
(chapters 6 and 7). Furthermore, this thesis makes an attempt to fit the findings of 
the various studies into current pathophysiological concepts of urogenital tract 
(dys)function. In those cases where the results do not comply with these concepts, 
new paradigms will be discussed. 
Finally, since classical methods such as somatosensory evoked potentials and sacral 
reflex latency measurements seem to leave an open space because of involvement 
with sensory pathways only, a new technique for the investigation of autonomic 
motor pathways will be introduced (chapter 8). Besides introduction of a new 
technique for the investigation of autonomic motor innervation of the urogenital 
tract, a critical appraisal of a recently introduced technique that was said to fulfil 
similar demands (penis-EMG) will be given (chapter 9). 
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EVIDENCE FOR EARLY LOWER URINARY TRACT DYSFUNCTION IN 
CLINICALLY SILENT MULTIPLE SCLEROSIS 
Results of comprehensive neurourodynamic testing in 40 patients 
Bart LH. Bemelmans, Otto R. Hommes, Philip E.V. Van Kerrebroeck, 
Wim A.J.G. Lemmens, Wim H. Doesburg and Frans M.J. Debruyne 
Journal of Urology, 145:1219, 1991. 
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Abstract 
The occurrence of micturition complaints as late sequela of multiple sclerosis is well 
studied and documented. However, no reports exist on urologically asymptomatic 
patients, with a relatively short disease duration. In a prospective study of 40 
patients with definite multiple sclerosis (mean disease duration, 5 years), urodynamic 
investigations (cystometry, pressure-flow study) were combined with neuro-
urophysiological measurements (cortical evoked potentials, sacral reflex latencies). 
Patients with (n=13) and without (n=27) micturition complaints were investigated. 
Neurourodynamic abnormalities were seen in 35 of 40 patients (88%). The lower 
urinary tract proved to be afflicted by multiple sclerosis at an early stage of the 
disease. Early neurourodynamic investigations had clinical implications. All of the 
complaining and half of the non-complaining patients showed urodynamic 
abnormalities upon which the need for further follow-up and eventual therapeutic 
intervention was based. We conclude that neurourodynamic testing of a "urinary 
functional system" can be worthwhile as part of the initial diagnostic evaluation in 
patients with proved multiple sclerosis. 
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Introduction 
Symptomatology of urogenital tract dysfunction in multiple sclerosis is extensive. 
Various studies exist on the subject of neurourodynamic investigations in patients 
with multiple sclerosis and concomitant symptoms of lower urinary tract 
dysfunction.1"5 
The incidence of complaints of urinary tract dysfunction varies from 50%3 up to 
97%.5 Presumably, every patient with multiple sclerosis sooner or later will have 
urinary tract dysfunction. However, clinical urogenital tract dysfunction is the first 
symptom of multiple sclerosis in only 2% of the patients.5,6 
Several authors found poor relationships between the subjective complaints and 
objective neurourologic parameters. Therefore, a neurourological diagnostic work up 
seems mandatory not only in patients with urological complaints, but also in those 
without such complaints. 
Patients complaints can be categorized according to involuntary urine loss, and 
obstructive symptoms, and irritative symptoms. Bladder hyperreflexia seems to be 
responsible for the majority of the morbidity in multiple sclerosis patients with 
urogenital tract dysfunction, especially when it is accompanied by vesico-sphincter 
dyssynergia.4 Our study indicates that objective lower urinary tract dysfunction can 
be present without complaints. 
Patients and Methods 
This prospective study concerns 40 consecutive patients, diagnosed as having definite 
multiple sclerosis according to the criteria of Poser7, who were admitted for 
neurological and urologie investigations. There were 25 women (mean age, 35 years; 
range, 22-55) and 15 men (mean age, 35 years; range, 21-59). Patients were divided 
in two groups: group I consisted of 13 patients (6 women, 7 men; mean age, 37; 
range, 23-59) with micturition complaints, group II consisted of 27 patients (19 
women, 8 men; mean age, 34 years; range, 21-55) without any complaint of lower 
urinary tract dysfunction. 
The diagnosis of multiple sclerosis was made by a neurologist experienced in this 
disease (O.R.H.). A complete history was obtained and physical examination was 
performed. Patient sex, age, duration of disease (DD) and disability status scale 
(DSS) were documented. If history revealed an optic neuritis many years before the 
onset of actual complaints of locomotor and/or sensory disorders, the event of this 
transient neuritis was taken as the onset of the disease. The progression rate (PR) 
was calculated as disability status scale divided by disease duration. Furthermore, the 
functional systems according to Kurtzke were scored.8 This evaluation concerned the 
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pyramidal, cerebellar, brain stem, sensory and visual functions on a scale of 0 
(normal) to 6 (severely impaired). A functional system was considered "afflicted" if a 
score of more than 0 was found. 
The course of the disease was documented in each patient as being exacerbating-
remitting (ER), chronic-progressive (CP) or as a combination of these (ER-CP). 
With respect to documentation by means of Magnetic Resonance Imaging (MRI) 
the intra-cranial lesions were scored as absent, clear but slight (mild), moderate or 
severe. Cerebrospinal fluid (CSF) was completely investigated and in all cases 
showed intrathecal IgG synthesis, increased IgG index, and oligoclonal banding. Only 
the amount of cells per 3 mm3 and of myelin basic protein (MBP) are presented. 
These two parameters are believed to be related to the activity of the disease. CSF 
was considered abnormal if more than 10 cells per 3 mm3 were found and/or if the 
amount of MBP exceeded 1.8 μg/l. 
Urological symptoms were recorded as irritative, obstructive, or involuntary urine 
loss. Blood samples were taken for Urea Nitrogen and Serum Creatinine, and 
ultrasound of the kidney's was performed to evaluate upper urinary tract 
involvement. Urine samples were taken for sedimentation and culture. 
In all 40 patients urodynamic as well as neuro-urophysiological investigations were 
performed. Methods, definitions and units conform to the standards recommended 
by the International Continence Society.9 Urodynamic testing consisted of a free 
flow study, urethral pressure profile measurement, cystometry and pressure-flow 
study together with electromyoghraphy registration of the pelvic floor muscles. 
Residual urine was measured by means of catheterization before and after the 
urodynamic investigation. Intra-vesical and abdominal pressures were measured with 
6 F micro-tip transducer catheters (Honeywell); pelvic floor electromyoghraphy was 
recorded with two surface electrodes (Hewlett Packard), attached in the vicinity of 
the anal sphincter. Water-cystometry was performed at a filling rate of 35 ml per 
minute through a 12 F silicone catheter. During urodynamic investigation special 
attention was paid to first desire to void and maximum cystometric capacity. A first 
desire to void of 200 ml or more, in combination with a maximum cystometric 
capacity of 500 ml or more, was considered pathologic (that is "hyposensitive"). In 
contrast, a first desire to void of 50 ml or less was considered "hypersensitive". 
Patients with some abnormality on urodynamic investigation (that is hypo· 
/hypersensitivity, hypocontractility/hyperreflexia, incontinence, or dyssynergia) were 
placed in group A, those with a normal urodynamic investigation were placed in 
group B. 
Somatic as well as visceral sensory nerves were investigated by a combination of 
tests including evoked potentials of the tibial and pudendal nerves, urethral sensory 
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perception threshold measurement, bulbocavernosus reflex latency, and urethro-anal 
reflex latency. 
Somatosensory evoked potentials were obtained with a commercially available 
stimulation and registration apparatus (Nicolet Compact-4). Consecutively, right and 
left tibial evoked potentials, pudendal evoked potentials, bulbocavernosus reflex 
latency and urethro-anal reflex latency were measured. 
The somatosensory evoked potentials were obtained by international standards. For 
determination of the sensory perception thresholds to electrical stimulation of the 
proximal urethra, a balloon catheter (МТС-Medical) with two ring electrodes 10 and 
20 mm from the base of the balloon was inserted into the bladder. The catheter 
was retracted after filling the balloon, thus allowing for direct electrical stimulation 
of the mucosa of the proximal urethra. The sensitivity threshold was defined as the 
lowest level (in mA) at which a patient could feel the square-wave pulses (stimulus 
duration, 0.2 ms; frequency, 1.3 Hz) as a throbbing or burning sensation. This 
measurement was repeated three times, taking the lowest value as the sensory 
threshold. Sensitivity threshold measured in this manner was compared to bladder 
sensitivity on cystometry (first desire to void) using the Wilcoxon two-sample test. 
To measure bulbocavernosus reflex latency, the pudendal nerves were 
supramaximally (60 mA) stimulated at the penis or clitoris. Recording in all patients 
was in the right upper quadrant (patient in lithotomy position) of the external anal 
sphincter muscle, with a concentric needle electrode (Dantec). In each patient at 
least 8 recordings were done. To measure urethro-anal reflex latency, the proximal 
urethra was stimulated through the previously described catheter, and the response 
was recorded as for the bulbocavernosus reflex. 
Using the normal values gathered in 86 healthy volunteers (50 men, 36 women)10, 
distinction was made between normal and pathological results of the neuro-
urophysiological investigations. If measurement of a sacral reflex latency 
(bulbocavernosus reflex and urethro-anal reflex) revealed a delayed or absent 
response, the electromyoghraphy needle was relocated and the recording was 
repeated. For this study only those somatosensory evoked potentials and sacral 
reflexes were considered "abnormal" in which repeated measurements were delayed 
or non-evokable. Non-evokability in somatosensory evoked potential or sacral reflex 
latency measurement was considered pathological, because this phenomenon was 
never seen in the healthy volunteers. 
For the statistical comparison of two sample-percentages Fishers exact test (two-
tailed) was used and for the comparison of two sample-distributions of an (at least) 
ordinal variable the Wilcoxon two-sample test was appropriate. If the p-value of the 
statistical test was smaller than or equal to 0.05 the difference between the two 
samples was called "statistically significant". To reflect differences in distribution it 
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was necessary to present mean values as well as median values. The ranges also are 
given. 
For statistical comparison of the neuro-urophysiological data the Gehan-Wilcoxon 
test was applied. Thus, the non-evokable responses were considered to be right-
censored (that is large value) data. 
Results 
The results of the neurological investigations are given in table 1. In our patients 
there are differences between women (25 patients) and men (15 patients). A shorter 
duration of disease and a higher disability status scale in the men, results in an 
almost statistically significant higher progression rate (Wilcoxon test, ρ = 0.08). Also 
for the cerebro spinal fluid-myelin basic protein investigations and MRI generally 
higher values were found in the men. These sex-related differences are reflected by 
the prevalence of micturition complaints. Micturition complaints were found in 13 
out of 40 patients (33%), and were twice as frequent in men (7 of 15 patients, 
47%) as in women (6 of 25 patients, 24%). In the group as a whole, irritative (10 of 
13 patients) and obstructive (7 of 13 patients) complaints were most frequent. Only 
one patient complained about urinary incontinence. 
Table 1: Results of neurological investigations for women and men 
number of Pis. 
DD (years) 
DSS 
Progression 
Rate 
MRI 
CSF-MBP 
(МЛ) 
No. of 
abnormal Pis. 
mean 
median 
range 
mean 
median 
range 
mean 
median 
range 
no lesions 
mild 
moderate 
severe 
mean 
median 
women 
25 
5.6 
5 
0.17-15 
2.72 
2 
1-6 
1.63 
0.67 
0.11-11.8 
4 
9 
7
 }=4B% 
5 
0.9 
0.6 
2 (8%) 
men 
15 
3.6 
2 
0.17-10 
3.47 
3 
1-7 
3.15 
1.17 
0.30-11.8 
1 
2 
5
 )=eo% 
7 
3.2 
1.4 
6 (40%) 
statistical comparison 
p-value 
0.27 
0.24 
0.08 
0.01 
0.01 
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Table 2; Comparison of the neurological investigations between group I (symptomatic) 
and group II (asymptomatic) 
number of Pts. 
women/men 
DD (yeais) 
DSS 
MRI 
Course of 
Disease 
mean 
median 
range 
mean 
median 
range 
no lesions 
mild 
moderate 
severe 
ER 
CP 
ER-CP 
complaints 
group I 
13 
6/7 
5.4 
6 
0.17-10 
3.69 
3 
1-7 
2 
1 
4 
6 > - 7 7 % 
6 
3 
4}-54% 
no complaints 
group II 
27 
19/8 
4.5 
2 
0.17-15 
2.67 
2 
1-6 
3 
10 
8 
g l - K * 
21 
2 
4>-22% 
statistical comparison 
p-value 
0.17 
0.31 
0.07 
0.06 
0.07 
The neurological investigations between group I (patients with micturition 
complaints) and group II (patients without micturition complaints) are compared in 
table 2. There is a higher disability status scale (p = 0.07) in the group I patients. 
Nevertheless, almost the same distribution of the progression rate for complaining 
and non-complaining patients was found (p = 0.97). On MRI examination there is a 
difference between patients with and without urinary symptoms. The former seem to 
have more frequently moderate and severe lesions (10 of 13; 77%) than the latter 
(14 of 27, 52%; ρ = 0.06). Patients with micturition complaints also seem to have 
more often a chronic-progressive course of disease (7 of 13, 54%) than the others 
(6 of 27, 22%; ρ = 0.07). 
No differences were found in comparing the neurological data of the 27 patients 
with abnormal (group A) and 13 with normal (group B) urodynamic investigations. 
Table 3: Overview of 27 patients with an abnormal urodynamic investigation (group A) 
Patient Sexe 
Urinary Complaints 
Obstructive Irritative Inconbnence Bladder 
Sensitivity 
Urodynamic Investigation 
Bladder Motor Urge Dyssynergla 
Contractility Inconbnence 
Neuro-urophysiological Investigation 
ТЕР R TEP-L PEP UAfí BCR 
JS 
PL 
FR 
VR 
WL 
PF 
WB 
DH 
SD 
VHP 
FJ 
EL 
TG 
hypo 
hyper 
hypo 
hypo 
hyper 
hyper 
hypo 
hyper 
hyper 
hyper 
hypo 
hyper 
hypo 
hyper 
hypo 
hyper 
hyper 
hypo 
46 
ne 
ne 
38 
42 
44 
ne 
38 
44 
72 
SO 
74 
SO 
52 
ne 
39 
41 
42 
36 
36 
38 
40 
40 
SS 
ne 
39 
52 
50 
ne 
ne 
39 
42 
48 
ne 
39 
43 
S4 
S3 
ее 
es 
4β 
47 
42 
42 
44 
40 
38 
40 
42 
39 
40 
ne 
39 
SO 
ne 
ne 
63 
52 
48 
ne 
SI 
37 
39 
79 
86 
7« 
45 
S4 
49 
4e 
49 
36 
40 
38 
40 
4S 
45 
57 
ne 
44 
S3 
44 
64 
SI 
47 
61 
70 
76 
73 
6S 
67 
61 
62 
ne 
64 
SS 
64 
S4 
83 
76 
90 
78 
ne 
79 
90 
84 
88 
ne 
27 
3S 
30 
28 
34 
31 
32 
30 
36 
ne 
27 
se 
44 
3β 
30 
37 
32 
eo 
83 
42 
24 
38 
44 
4S 
ne 
4« 
ne 
DL 
LS 
RM 
WN 
JK 
GK 
SJ 
FL 
BE 
DK 
SP 
CK 
JJ 
HB 
hypo 
hypo 
hypo 
hypo 
hypo 
hyper 
hypo 
hypo 
hyper 
hypo 
hypo 
hypo 
hyper 
hyper 
hypo 
hyper 
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Bladder hypersensitivity was found in 6 patients, and bladder hyposensitivity was 
diagnosed in 14 cases. In the former patients the first desire to void was equal to or 
less than 50 ml, with a mean maximum cystometric capacity of 270 ml (range, 130 -
450 ml). In the latter patients the mean first desire to void was 375 ml (range, 200 -
750 ml), whereas mean maximum cystometric capacity was 710 ml (range, 500 - 850 
ml). 
In the remaining 20 ('normo-sensitive') patients these figures were 150 ml (range, 
100 - 220), and 425 ml (range, 140 - 650), respectively. 
The combination of urologica! complaints and urodynamic investigations revealed 
some remarkable data. In our study there was good agreement between the nature 
of micturition complaints and abnormalities on urodynamic investigation. Patients 
with irritative micturition complaints more often showed bladder hypersensitivity (p 
= 0.15) and detrusor hyperreflexia (p = 0.04) on urodynamic investigation, while 
those who had obstructive complaints more often had detrusor hypocontractility and 
postvoiding residual urine (p = 0.03). The finding of a hyposensitive bladder on 
urodynamic study did not correlate with patients complaints (p = 0.98). 
Only 4 of 14 patients with a hyposensitive bladder on cystometry had urinary 
symptoms. Impairment of bladder sensation apparently did not lead to any 
complaint in the other 10 patients (table 3.). 
The finding of many urodynamic abnormalities in the non-complaining patients is 
important. Of the 27 patients with no micturition complaints at all (group II), 14 
(52%) had abnormalities on urodynamic investigation (table 4). All 13 
Table 4: Patients with abnormal (Group A) and normal (Group B) urodynamic 
investigations, compared with patients with (Group I) and without 
(Group ¡I) urinary complaints 
Group I: micturition complaints 
Group II: no micturition complaints 
Total 
Urodynamic 
Group A 
abnormal 
13 
14 
27 
Investigation 
Group В 
normal 
-
13 
13 
Total 
13 
27 
40 
Figure 1: Comparison of neuro-urophysiological measurements between symptomatic 
(group I) and asymptomatic patients (group II)S 
TEP (f> TIP (1) PEP UAR ВСЯ 
tl I II [ 11 I 11 1 
G oup G ου ρ G ojp G oup G DUP 
The normal values gathered in 86 healthy volunteers (50 men, and 36 women) are marked by the 
dotted lines (mean ± 2 SD) ТЕР, 35-46 ms, PEP, 36-47 ms; UAR, 46-75 ms, BCR, 22-40 ms. 
TEP-Right: group I, median, 50 ms - group II, median, 42 ms (p-value, 0.09). TEP-Left: group I; 
median, 53 ms - group II, median, 42 ms (p-valuc, 0 03) PEP group I, median, 63 ms - group II; 
median, 46 ms (p-value, 0 06). UAR group I, median, 64 ms - group II, median, 67 ms (p-value, 
0.12). BCR. group I, median, 32 ms - group II, median, 38 ms (p-value, 0 10). 
Figure 2: Comparison of neuro-urophysiological measurements between patients 
with an abnormal (group A) and a normal urodynamic investigation 
(group B)* 
TEP (rj TEP (I) PEP UAH BCR 
For normal values, see fig. 1. TEP-Right: group A, median, 44 ms - group B; median, 42 ms (p-
value, 0.56). TEP-Left: group A; median, 44 ms - group B, median, 43 ms (p-value, 0.79). PEP: 
group A; median, 49 ms - group B, median, 46 ms (p-value, 0.49). UAR: group A, median, 72 ms 
- group B; median, 65 ms (p-value, 0.15). BCR- group A; median, 38 ms - group B; median, 34 
ms (p-value, 0.38). 
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patients with micturition complaints (group I) had an abnormal urodynamic study. 
Therapeutic intervention was based upon the urodynamic fìndings. Detrusor 
hyperreflexia was treated accordingly in 9 patients with anti-spasmodic or anti-
cholinergic drugs. In 5 patients significant post-voiding residual urine was treated 
with intermittent clean catheterization. The 14 patients with a diagnosis of bladder 
hyposensitivity were placed on a fixed micturition regimen (that is voiding every 
three to four hours during the daytime). Furthermore, the interval to follow-up was 
influenced by the presence of abnormal urodynamic findings. 
Neuro-urophysiological findings are shown in figure 1. In the patients with (group I) 
and in without (group II) urinary complaints a vast number of abnormalities were 
found. The p-values given in figure 1 indicate that the neuro-urophysiological 
differences between complaining and non-complaining patients are statistically almost 
significant: In group I there was a predominance of abnormal somatosensory evoked 
potentials: 8 of 13 complaining patients (62%) had abnormal somatosensory evoked 
potentials together with normal sacral reflexes, whereas only 1 (8%) had abnormal 
sacral reflexes and at the same time normal somatosensory evoked potentials. In 
contrast, in the non-complaining group II more abnormal sacral reflex latencies were 
found: 12 of 27 non-complaining patients (44%) had abnormal sacral reflexes with 
normal somatosensory evoked potentials, whereas 7 (26%) had abnormal 
somatosensory evoked potentials with normal sacral reflexes. 
In the patients with an abnormal outcome of the urodynamic investigation (group 
A) deviant evoked potentials and sacral reflex latencies were equally frequent as in 
those of group В (see figure 2). The urodynamic finding of a hyposensitive bladder 
correlated well with the perception threshold of the urethral mucosa. In the 14 
patients with a hyposensitive bladder, the mean urethral perception threshold was 
13.4 mA (range, 5-38), while in the other 26 patients it was 7.8 mA (range, 2-26; 
Wilcoxon test, ρ = 0.03). 
There was good correlation between the right and left tibial evoked potentials 
(Kendall correlation coefficient: 0.69). From this bi-lateral involvement of central 
neural pathways can be concluded in the majority of cases. Fairly good correlation 
was found between tibial and pudendal evoked potentials (Kendall corr. coeff.: 
0.50). Correlation between bulbocavernosus reflex and urethro-anal reflex was poor 
(Kendall corr. coeff.: 0.26). 
Table 5 shows an overview of the numbers of abnormal patients for the urodynamic 
and neuro-urophysiological investigations. For the group as a whole, some 
abnormality was found in 35 patients (88%). In 27 patients the urodynamic 
investigation was abnormal, and in 31 patients the neuro-urophysiological 
measurements showed abnormal results. 
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Table 5: Comparison of the outcome of the urodynamic and neuro-
urophysiological investigations 
Urodynamic Investigation 
Neuro-urophysiological 
Investigation: abnormal 
Neuro-urophysiological 
Investigation: normal 
Total 
Group A 
abnormal 
23 
4 
27 
Group В 
normal 
8 
5 
13 
Total 
31 
9 
40 
In all 40 patients urine samples were negative. None of the patients showed 
elevated levels of Urea Nitrogen or Plasma Creatinine, and in all patients ultra­
sound of the kidney's was normal. 
Discussion 
This is the first neurourodynamic comparison of multiple sclerosis patients with and 
without urinary complaints. The general prevalence of urinary symptoms is lower 
than reported in previous urodynamic studies. Only a third of the patients 
investigated had micturition complaints. This probably is due to the fact that our 
patients were relatively young (mean age, 35 years for both sexes), with a short 
duration of disease (5.4 years in the symptomatic, and 4.5 years in the asymptomatic 
patients). In a study by Awad et al, who reported urinary symptoms in half of the 
patients, mean age was 45 years for the women and 46 years for the men. Disease 
duration in their study was 18 years in the symptomatic, and 12 years in the 
asymptomatic patients.3 
At the time of our study, none of our patients showed any sign of upper urinary 
tract affliction. Although a lower incidence of urinary symptoms was found, there 
was objective urodynamic evidence of lower urinary tract dysfunction in 27 of 40 
multiple sclerosis patients (68%). Of course the determination of urodynamic 
abnormalities depends on the definitions used. To date, the Standardization 
Committee of the International Continence Society has not yet defined normative 
data for cystometric parameters. Especially, our definition of bladder hyposensitivity 
on cystometry (that is first desire to void of 200 ml or more and maximum 
cystometric capacity of 500 ml or more) might be somewhat arbitrary. The fact that 
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so defined bladder hyposensitivity corresponded well with urethral perception 
threshold might give support to this definition. In any case, urodynamic parameters 
were defined beforehand and in such a way that the finding of a deviant 
investigation would lead to rational therapeutic measures. The main goal was to 
prevent patient morbidity, and to improve quality of life, as well as long term 
prognosis. With regard to the central nervous system, objective neurourodynamic 
evidence of affliction of the lower urinary tract was even more frequent: 31 of 40 
patients (78%) had abnormal cortical evoked potentials and/or sacral reflex 
latencies. 
The most important finding of this study was the sizeable percentage of urodynamic 
abnormalities in urologically silent multiple sclerosis patients. Half of the patients 
(14 out of 27 asymptomatic patients, 52%), who did not forward urinary complaints 
at interrogation, had objective urodynamic abnormalities. Most certainly, bladder 
hyposensitivity was responsible for this large amount of urologically silent patients 
(10 of 14). Patients with decreased bladder sensitivity are likely not to complain 
about bladder dysfunction. 
Urodynamic investigation of 27 patients without urinary symptoms showed 
therapeutic consequences in 14. In 3 patients in whom urodynamic investigation 
revealed detrusor hyperreflexia, anti-cholinergic or anti-spasmodic drugs were 
prescribed; and the patient with important post-voiding residual urine was begun on 
intermittent clean catheterization. The 10 non-complaining patients with a 
hyposensitive bladder were placed on a fixed micturition regimen. Although these 
patients had no initial complaints, therapeutic measures seemed favourable to 
ameliorate quality of life and eventually to prevent imminent complications. Further 
prospective analysis of this group will prove this event in the long term. 
Patients with urinary symptoms seem to have a more serious affliction of the central 
nervous system. Table 2 shows that patients with urinary complaints (group I) have 
a higher disability status scale, more lesions on MRI, and more often a chronic-
progressive course of disease. Figure 1 proves more frequent damage to central 
neural pathways (right/left tibial evoked potentials and pudendal evoked potentials) 
in the symptomatic patients. 
The neuro-urophysiological investigation might be helpful to determine the exact 
localization of the lesions, as was suggested by Haldeman et al.11 In combination 
with other neurourological diagnostic features it might contribute to localise the 
demyelinated foci and to predict future sequelae.12 In patients with urinary 
complaints (group I), the combination of abnormal somatosensory evoked potentials 
and normal sacral reflex latencies was frequently encountered. This suggests that 
damage to supra-sacral neural tracts, together with integrity of sacral neural 
networks, constitutes the anatomical substrate in patients with urinary symptoms. 
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Table 3 shows that especially those symptomatic patients with bladder hyperreflexia, 
a cystometric sign pathognomonic for upper motor neuron lesions, present with 
isolated supra-sacral lesions on somatosensory evoked potential studies. Apparently 
there is good correlation between urodynamic signs of upper motor neuron disease 
and neuro-urophysiological prove of supra-sacral neural tract affliction. 
As to the possible localization of the disease, the good correlation between right 
and left tibial evoked potential proves a bi-lateral involvement of central neural 
pathways. Furthermore, the poor correlation between bulbocavernosus reflex and 
urethro-anal reflex indicates that the neuro-urophysiological investigation of 
somatic13 (bulbocavernosus reflex) and visceral14,15 (urethro-anal reflex) afférents 
deals with two separate parts of lower urogenital tract innervation, with distinct 
involvement in the demyelinating process. Since bulbocavernosus reflex and urethro-
anal reflex have the same motor outflow (figure 2, chapter 1), the finding of a poor 
correlation between bulbocavernosus reflex and urethro-anal reflex indicates that 
multiple sclerosis has an important impact on the afferent (sensory) portion of the 
sacral reflex arc in an early stage of the disease. Wheeler et al suggested 
preponderance of suprasacral motor neural tract involvement in patients with 
multiple sclerosis.16 Also the finding of a vast number of abnormal somato-sensory 
evoked potentials, and hyposensitive bladders on urodynamic investigation proved 
the importance of sensory disorders in an early stage of the disease. 
In only S of our patients was a normal neurourodynamic investigation found. 
Obviously, the urinary tract is an organ system highly susceptible to multiple 
sclerosis. Whereas some of the neurological parameters (Progression Rate, 
Functional Systems, and Cerebro Spinal Fluid) proved to be unsuited to differentiate 
between patients with and without urinary symptoms (table 2), the neurourodynamic 
parameters differ significantly for both groups (table 3), with the exception of 
bladder hyposensitivity. 
According to Kurtzke, bowel and bladder function is graded on a 0 to 5 scale.8 We 
propose to add a diagnostic evaluation of a "urinary functional system" in a manner 
described in our study to a routine diagnostic evaluation for multiple sclerosis. 
Our neurourodynamic studies proved early involvement of the lower urinary tract. 
Because of this, we decided to make this assessment part of an ongoing research 
protocol. We believe that early treatment, based upon objective criteria, and closer 
follow-up can improve morbidity and quality of life. In prospective studies we will 
investigate whether early treatment will benefit individual multiple sclerosis patients. 
Eventually, we will learn if it is worthwhile to submit each patient to such 
comprehensive, and invasive investigations as proposed in our study. Selection 
criteria for such diagnostic procedures must be established. 
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Abstract 
A total of 123 patients with complaints of erectile dysfunction and no clinically overt 
neurological disease underwent a comprehensive neuro-urophysiological diagnostic 
evaluation. The results were compared with those obtained in SO healthy volunteers. 
Data gathered consisted of somatosensory evoked potentials from the posterior tibial 
nerve (tibial evoked potential), and from the dorsal penile nerve (pudendal evoked 
potential). Also two sacral reflex latencies were measured (bulbocavernosus reflex 
and urethro-anal reflex). A total of 58 patients (47%) had at least one abnormal 
neuro-urophysiological measurement. Neuro-urophysiological abnormalities were 
found more frequently in older patients. Tibial evoked potential was abnormal in 30 
patients (24%), pudendal evoked potential in 21 patients (17%), bulbocavernosus 
reflex in 26 (21%), and urethro-anal reflex in 32 (26%). It was concluded that 
somatosensory disturbances constitute an important part of neuro-urophysiological 
abnormalities. Our results study suggest a relationship between erectile dysfunction 
and subclinical, age-related (penile) sensory disorders. Our study corroborates the 
importance of penile sensibility for erectile (patho)physiology as suggested by other 
authors, and supports the concept of sensory-deficit impotence as an important 
cause of erectile dysfunction. 
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Introduction 
Many investigators have stressed the importance of evoked potentials for the 
diagnosis of neurological disorders of the urogenital tract. Bradley et al used 
urethral electromyography to delineate neuropathic involvement of the lower urinary 
tract in neurological disease.1 Ertekin and Reel found the bulbocavemosus reflex to 
be of great value in the differential diagnosis of urogenital tract dysfunction.2 Siroky 
et al and Krane and Siroky obtained excellent correlation between prolonged latency 
of the bulbocavemosus reflex and clinical evidence of neuropathy in patients with 
suspected neurological disease (diabetes mellitus, multiple sclerosis, Miles' resection 
of the rectum, herniated disk and toxic neuropathy).3,4 Haldeman et al, Badr et al, 
and Opsomer et al were able to obtain cortical evoked potentials after stimulation 
of somatic and visceral peripheral nerves.5"7 Anten et al described the possibility of 
localizing neurological lesions in patients with urologica! dysfunctions by combining 
somatic and visceral evoked potentials with sacral reflex latencies.8 
Evoked potentials and sacral reflex latencies have been used as a diagnostic tool in 
neurological patients with erectile dysfunction by Lin and Bradley, Buvat, Ertekin, 
and Tackmann et al.9"12 However, none of these investigators used the combination 
of somatosensory evoked potentials with the latency of urethro-anal reflex and 
bulbocavemosus reflex. We attempted to relate findings of a comprehensive 
neurophysiological diagnostic evaluation, which consisted of a combination of 
somatosensory evoked potentials and sacral reflex latencies, to clinically relevant 
parameters, such as patient age, medical history, intoxications, outcome of intra-
cavernous pharmacological testing and hormonal profile in 123 neurologically 
unsuspected patients. 
Patients and Methods 
For this study we examined 171 consecutive patients (mean age, 52 years; range 17-
77 years) with complaints of erectile dysfunction. From each we obtained a detailed 
history focusing on sexual function, neurological disease, and potential toxic factors 
such as smoking of cigarettes, alcohol abuse, or exposure to neurotoxic chemicals. 
Based on history and physical examination, 48 patients were excluded from this 
study, because a neurological etiology for erectile dysfunction was suspected: 21 
patients with diabetes mellitus, 21 whose erectile dysfunction appeared immediately 
after surgical intervention in the pelvis (radical prostatectomy, transurethral prostatic 
resection, or sigmoid resection), and 6 who became impotent after laminectomy 
because of a herniated disc. 
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None of the patients included in this study complained of numbness or other 
sensory disorders, neither in the genitalia nor in the hands or feet. Physical 
examination revealed no indication of neurological disease. 
In each patient an intracavernous pharmacological testing (papaverine-hydrochloride) 
was performed with an initial dosage of 50 mg. Because induction of erection by 
papaverine injection may be influenced by external factors such as stress and 
anxiety, a negative papaverine test was repeated once at a later occasion to increase 
its diagnostic accuracy.13 In all patients with an erectile response to 50 mg 
papaverine, the erectile response to 25 mg was tested. 
Blood samples were taken for plasma levels of testosterone, luteinizing hormone, 
prolactin and plasma glucose. 
Evoked potentials were obtained with a commercially available stimulation and 
registration apparatus (Nicolet Compact-4). Neuro-urophysiological studies consisted 
of measurement of the tibial evoked potential (ТЕР), pudendal evoked potential 
(PEP), bulbocavemosus reflex (BCR) latency, and urethro-anal reflex (UAR) latency 
(figure 2, chapter 1). A total of 50 healthy male volunteers without complaints of 
erectile dysfunction was investigated as a control group. 
Neuro-urophysiological investigations were done with the patients in the supine 
position, in a room with a constant temperature of 25 0C. The somatosensory 
evoked potentials were obtained with bipolar percutaneous stimulation (stimulus 
duration, 0.2 ms; frequency, 2.7 Hz) of the posterior tibial nerve at the ankle of the 
right foot (tibial evoked potential), and the dorsal penile nerve on the dorsum of 
the shaft of the penis (pudendal evoked potential), with the cathode proximal to the 
anode. For the tibial evoked potential stimulation intensity was considered accurate 
if twitching of the toes was clearly visible; for the pudendal evoked potential 
stimulation intensity was at least twice the sensory threshold. The evoked potentials 
were recorded with silver plated cup electrodes from the Cz-2 point (2 cm behind 
Cz) determined with the international 10-20 system.14 Electrode resistance was kept 
below 1.5 kn. We averaged 200 stimuli (high frequency filter setting at 1500 Hz; low 
frequency filter setting at 50 Hz; sensitivity, 100 μΥ). Latency time was defined as P, 
at the first positive (downward) deflection of an averaged curve. All curves were 
measured twice to evaluate repeatability. Curves in which the cortical response could 
not be identified were classified as "non-evokable". 
We also determined sensory thresholds to electrical stimulation of the mucosa of the 
proximal urethra using an indwelling balloon catheter (MTC-Medical) with two ring 
electrodes 10 and 20 mm from the base of the balloon. After insertion into the 
bladder and filling of the balloon the catheter was retracted, allowing for direct 
electrical stimulation of the urethral mucosa. The sensory threshold was defined as 
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the lowest level (in mA) at which a patient could feel the square-wave pulses 
(stimulus duration, 0.2 ms; frequency, 1.3 Hz) as a throbbing or burning sensation. 
This measurement was repeated three times, taking the lowest value as the sensory 
threshold. During the entire procedure continuous bladder drainage was warranted 
by a drainage bag attached to the catheter. 
To measure bulbocavernosus reflex latency, penile stimulation was done on the 
penile shaft as in the pudendal evoked potential. Recording was in the right ventral 
quadrant of the external anal sphincter muscle with a concentric needle electrode 
(Danlec), a technique favoured by Hassouna et al.'5 To measure urethro-anal reflex 
latency, we stimulated the proximal urethra and recorded the response as for the 
bulbocavernosus reflex. For sacral reflexes, 8 separate latency measurements were 
recorded with supramaximal square-wave stimuli of 60 mA (stimulus duration, 0.2 
ms). Thus, consistent and repeatable measurements were obtained. If measurement 
of a sacral reflex latency (bulbocavernosus reflex and urethro-anal reflex) revealed a 
delayed or absent response, the electromyography needle was reinserted into the left 
ventral quadrant and the recording was repeated. In that case shortest latency was 
used for further evaluation. For our study only those sacral reflexes were considered 
"abnormal" in which repeated recordings gave delayed or non-evokable responses. 
In all patients, we recorded the electromyographic activity of the anal sphincter at 
rest and at voluntary contraction, to evaluate needle localization. Special attention 
was paid to electromyographic signs of denervation, such as fibrillation potentials, 
positive sharp waves and polyphasic potentials. 
To evaluate reproducibility of the neurft-urophysiological technique, we repeated the 
complete investigation in 10 randomly selected patients with an interval of 6 weeks 
to 6 months between consecutive investigations. All patients gave informed consent 
to a second test. Reproducibility was calculated with the coefficient of reliability.16 
Determination of reliability took into account instrumental and physiological 
variations within a patient between time-points as well as biological variations 
between patients. 
On the basis of reference values found in 50 healthy male volunteers with a history 
of normal erectile potency, we distinguished between normal and pathological results 
of the neuro-urophysiological investigations and formed two groups. Group I 
consisted of patients without abnormal neuro-urophysiological findings, and group II 
consisted of patients with at least one neuro-urophysiological measurement above 
the normal range. Non-evokability in somatosensory evoked potential or sacral reflex 
latency measurement was considered pathological, because this phenomenon was 
never seen in the 50 volunteers. Patients in whom it occurred were placed in group 
II. 
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For statistical comparison of two-sample percentages Fisher's exact test (two-tailed) 
was used, and for the comparison of two-sample distributions of an (at least) ordinal 
variable the Wilcoxon two-sample test was appropriate. If the p-value of the 
statistical test was smaller than or equal to 0.0S the difference between the two 
samples was considered "statistically significant". 
Results 
The results of the measurements of somatosensory evoked potentials and sacral 
reflex latencies in the 50 volunteers (mean age, 45 years; range, 29-62) are given in 
table 2, chapter 1. Our reference values are well in accordance with those reported 
in the literature. The mean age of the control group was 45 years (range, 29-62 
years). Of the 123 patients 65 (53%) were without any abnormal finding (group I), 
whereas 58 (47%) showed 1 or more abnormal latencies (group II). The mean age 
of the 65 patients in group I was 49 years (range, 26-68 years) and of the 58 
patients in group II it was 54 years (range 23-77, years). The age differences 
between group I and II are statistically significant (Wilcoxon two-sample test, 
ρ = 0.038). Age dependence of neuro-urophysiological abnormalities is illustrated in 
table 1. 
Table 1: Percentages of neuro-urophysiological abnormalities in patients of 
different age categories 
age category 
23 - 39 years 
4 0 - 4 9 
5 0 - 5 9 
6 0 - 7 7 
Total 
no. of Pts. 
21 
33 
41 
28 
123 
abnormal NUPHI 
7 
15 
20 
16 
58 
% 
33% 
45 
49 
57 
47% 
In the patients with normal or delayed evoked potentials, it was easy to obtain 
several curves, with a consistent and repeatable Ρ,-latency. In those, in whom the 
response was not clearly evokable, repeated measurements consistently remained 
unidentifiable. 
Tibial evoked potential was delayed or non-evokable in 30 out of 123 patients 
(24%), and pudendal evoked potential in 21 patients (17%). Therefore, peripheral 
neuropathies contributed importantly to the high amount of abnormalities found in 
this study. Affliction of the central (supra-sacral) neuraxis seemed less important, 
because in only 4 patients was the combination of abnormal tibial evoked potential 
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and pudendal evoked potential, together with normal bulbocavemosus reflex and 
urethro-anal reflex found. Also the poor correlation between tibial and pudendal 
evoked potentials in group II (Kendall's correlation coefficient, 0.12) suggested little 
importance of supra-sacral lesions in our patients, since both evoked potentials 
travel along the same supra-sacral neural pathway. If lesions would have been 
localized in the supra-sacral neural pathway (that is dorsal columns, figure 1), 
correlation would have been high. In a similar study on 40 patients with definite 
multiple sclerosis, a disease know for afflicting central neural pathways, we found a 
correlation coefficient for tibial and pudendal evoked potentials of 0.50.17 
Figure 1: Schematic overview of peripheral and central neural pathways for ТЕР 
and PEP 
central 
peripheral 
The median value of the sensory threshold of the proximal urethra was 8 mA 
(range, 2-61) in the 65 patients in group I, and 14 mA (range, 2-74) in the 58 
patients in group II (p = 0.08). Therefore, although the differences in urethral 
sensitivity between normal and abnormal patients with erectile dysfunction are 
sizeable, this measurement seems not very valuable for use in clinical practice 
because of the wide range of values in both groups. 
On insertion of the concentric electromyography needle, all patients showed normal 
insertion activity. With voluntary contraction of the external anal sphincter, all 
patients showed an interference pattern on electromyography registration, indicating 
PEP 
ТЕР 
64 Chapter 5 
correct needle placement and fair function of central and peripheral motor 
pathways. No signs of denervation were seen. 
The bulbocavernosus reflex was found to be abnormal in 26 patients (21%). The 
urethro-anal reflex was abnormal in 32 (26%). The combination of abnormal sacral 
reflexes (urethro-anal reflex and/or bulbocavernosus reflex) and normal evoked 
potentials (tibial and pudendal evoked potential) was found in 18 patients. 
Therefore, besides peripheral neuropathy, sacral neuropathic involvement was 
remarkable frequent in our patients. 
Kendall's correlation coefficient for bulbocavernosus reflex and urethro-anal reflex 
measurement was 0.20 in group I, and 0.18 in group II. Therefore, an abnormal 
bulbocavernosus reflex was not necessarily accompanied by an abnormal urethro-
anal reflex, and vice versa. 
The results of the repeated measurements in 10 randomly selected patients are 
given in table 2. Coefficients of reliability were 0.99 for tibial evoked potential, 0.95 
for pudendal evoked potential, 0.89 for urethro-anal reflex, and 0.93 for 
bulbocavernosus reflex. These figures show excellent agreement between consecutive 
measurements. Reproducibility of the neuro-urophysiological technique, therefore, 
seems to be beyond any doubt. 
Smoking habits were recorded in 106 patients. Of our patient population 48 (45%) 
were heavy smokers (more than 10 cigarettes daily). Of these 48 heavy smokers 20 
(42%) had an abnormal neuro-urophysiological investigation compared to 19 (43%) 
of the 44 non-smokers. Obviously, the outcome of the neuro-urophysiological 
investigation did not depend on smoking habits. 
The pharmacological test was performed according to the aforementioned criteria 
(that is at least one repetition of the test after a previous negative test) in 117 
patients. The test showed adequate rigidity in 71 patients, and it was consistently 
negative in 46. No patient had a prolonged erection (longer than 6 hours) or 
priapism. In all 71 patients with a positive papaverine test we attempted to decrease 
the dosage to 25 mg, with erection remaining adequate and this was successful in 
17. Comparison of the outcome of the neuro-urophysiological investigation in these 
17 patients with 54 patients, who consistently needed 50 mg for full rigidity, is given 
in table 3. No relation was found between the dosage necessary to gain full rigidity 
at pharmacotesting and the outcome of the neuro-urophysiological investigation. 
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Table 2: Comparison of latencies of repeated ТЕР, PEP, VAR and BCR 
measurements in 10 randomly selected patients (ne = non-evokable) 
J.V. 
P.J. 
J.D. 
J.L. 
J.M. 
P.C. 
CB. 
H.S. 
L-J. 
P.J. 
reliability 
age 
52 y. 
64 
55 
42 
60 
31 
30 
67 
57 
46 
ТЕР 
1st 
43 
42 
64 
55 
56 
43 
44 
49 
43 
44 
2nd 
43 
42 
63 
52 
55 
46 
44 
49 
42 
44 
0.99 
PEP 
1st 
48 
41 
44 
53 
44 
41 
36 
ne 
45 
41 
2nd 
47 
43 
44 
50 
44 
44 
38 
ne 
43 
39 
0.95 
UAR 
1st 
73 
53 
57 
80 
ne 
59 
64 
66 
67 
59 
0.89 
2nd 
61 
53 
64 
85 
ne 
59 
70 
64 
69 
62 
BCR 
1st 
39 
28 
32 
33 
37 
33 
38 
41 
31 
27 
2nd 
38 
28 
32 
37 
38 
28 
35 
41 
27 
27 
0.93 
Table 3: Patients with adequate reaction to papaverine-hydrochloride, 25 mg and 
50 mg respectively 
Papaverine Test Normal NUPHI Abnormal NUPHI Total 
pos., 25 mg. 
pos., 50 mg. 
neg. 
9 Pis. 
27 
24 
8 Pis. 
27 
22 
17 
54 
46 
Total 60 57 117 
Of 100 patients for whom complete hormonal profiles were available, 11 had 
abnormal levels of testosterone (less than or equal to 11 nmol/1). No abnormal 
levels of luteinizing hormone, prolactin, and plasma glucose were found. Of these 11 
patients with low testosterone levels 5 had normal neuro-urophysiological 
measurements, and 6 had deviant measurements. Therefore, from these figures no 
influence of testosterone levels on the outcome of the neuro-urophysiological 
investigation could be concluded. 
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Discussion 
The neuro-urophysiological examination presented was well tolerated by the patients. 
Our experience was that it takes some time for the clinical investigator to familiarize 
with the technique. Extensive information to the patient, together with an 
understanding and supportive approach, added to a high degree to the success of 
the investigation. After a learning curve, this technique appeared to be easy to 
perform and reproducible. 
In comparison to SO volunteers with normal erectile potency, the combination of 
investigatory techniques for somatic and visceral neuro-urological pathways, revealed 
abnormalities in 58 of 123 impotent patients (47%). With the same normal values, 
Porst et al found even higher numbers of abnormalities (up to 66%) on 
investigation of somatic tracts (pudendal evoked potential and bulbocavemosus 
reflex) only.18 On statistical grounds 1 or more abnormalities can be expected within 
a normal group in up to 9.6% (that is [1 - 0.9754] χ 100%) when 4 measurements, 
each with a specificity of 97.5%, are combined. This means that the finding of 47% 
abnormalities is impossible due to hazard. 
In our study delayed stimulus conduction, and processing along peripheral and sacral 
neural pathways proved to be related to patient age to a statistical significant 
degree. Edwards and Husted suggested collagen infiltration, arterio-sclerotic 
malnutrition and progressive peripheral neuropathy as possible causes for age-
related decrease in penile sensitivity and sexual activity.18 Our study supports this 
suggestion, that peripheral neuropathy and decrease in penile sensitivity are causally 
related to erectile dysfunction. It was shown that peripheral neuropathy together 
with sacral neurological disturbances account for the major portion of the 
abnormalities. These disturbances are localized in the sensory neural pathways. For 
peripheral tibial and pudendal nerves this is obvious, because tibial and pudendal 
evoked potential deal with sensory nerves only. For penile innervation this proof is 
derived from neuroanatomy. Afferent nerves of the urethro-anal and bulbo­
cavemosus reflex run along 2 distinct pathways: Autonomic pelvic nerve fibres for 
the urethro-anal reflex and somatic pudendal nerve fibres for the bulbocavemosus 
reflex.1,5,20 In the sacral spinal cord autonomic neurons are distinguishable from 
somatic neurons.21 For both sacral reflexes motor outflow proceeds through 
pudendal nerve fibres (figure 2, chapter 1). Therefore, although closely related, the 
bulbocavemosus reflex and the urethro-anal reflex reflect different afferent pathways 
of urogenital tract innervation. The absence of any significant correlation between 
pathological autonomic reflexes (urethro-anal reflex) and abnormal somatic reflexes 
(bulbocavemosus reflex; Kendall's correlation coefficient, 0.18) suggests that the 
neurological impairment in our patients is localized in the afferent (sensory) limb; it 
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also shows that the somatic and visceral afferent limbs of the reflex arcs can be 
afflicted separately. 
Another argument for the importance of sensory disorders is found in the outcome 
of the urethral sensory threshold measurements, that revealed higher sensory 
thresholds in patients with neuro-urophysiological abnormalities. 
The importance of penile sensory input for the physiology of erection was 
underlined by Herbert, who in a study of the rhesus monkey showed that sexual 
activity, and the ability to ejaculate were dependent on dorsal (sensory) penile nerve 
function.22 With respect to the physiological explanation it was stated that sensory 
input from the genitalia arouses central reflexogenic erectile mechanisms. Genital 
sensory input also evokes psychogenic sexual responses, and consequently stimulates 
sexual responsiveness. 
In regard to this important role of penile sensitivity in the physiology of erection, 
the high incidence of age-related sensory disorders in a sub-population of 58 
impotent men indicates that sensory-deficit impotence, a concept introduced by 
Padma-Nathan, may be an important causal factor of erectile dysfunction in the 
elderly.23 Sensory-deficit impotence refers to impotent men with abnormal pudendal 
evoked potential and bulbocavernosus reflex studies. Clinically, these patients merely 
suffer from weak erections too short in duration and from ejaculatory difficulties, 
than from pure absence of tumescence and rigidity. 
The concept of sensory-deficit impotence is supported by the findings of Lavoisier et 
al. In a study of 19 patients with abnormal bulbocavernosus reflex measurements, 
they found normal erections on nocturnal penile tumescence monitoring in 8 
patients.24 Because of this finding they concluded that measurement of 
bulbocavernosus reflex latency is not accurate for the diagnosis of neurogenic 
impotence. In our opinion, however, the combination of abnormal bulbocavernosus 
reflex and normal nocturnal penile tumescence does not exclude a neurogenic cause 
for erectile dysfunction, because patients with sensory-deficit impotence are likely to 
have normal nocturnal penile tumescence studies. In fact all 19 patients with penile 
sensory disturbances on bulbocavernosus reflex studies had some type of erectile 
potency left: Not only the 8 with normal nocturnal penile tumescence, but also the 
11 with "abnormal" nocturnal penile tumescence were reported to have nocturnal 
periods of penile rigidity. Obviously, all 19 patients suffered from sensory-deficit 
impotence. 
Our own study, which shows a remarkably high number of abnormal pudendal 
evoked potential, urethro-anal reflex and bulbocavernosus reflex latencies, and the 
studies as cited previously, seem to prove the presence and the clinical importance 
of subclinical sensory disorders of the penis in impotent men. Surely, more 
fundamental research is needed to elucidate the exact clinical implications of these 
findings, as well as their precise nature and cause. 
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Apart from the process of aging, no clue to the underlying cause of sensory 
disorders was found. After all, all patients, who because of their histories were likely 
to have neurogenic impotence were excluded from this study. Bradley et al and 
Ertekin and Reel suggested the possibility of cortical interference with sacral reflex 
latency.1,2 Their findings are not confirmed by our study, because no correlation was 
found between bulbocavernosus reflex and urethro-anal reflex. One would expect 
these cortical influences to have equal impact on both sacral reflexes. Also the 
excellent reproducibility of the measurements is in contradiction with some type of 
suprasacral interference. 
Smoking habits did not cause neuro-urophysiological abnormalities. Besides smoking 
of cigarettes, perhaps contact of individual patients with toxic agents at work or at 
home (food or environment) is important. Indeed, we found that a 42-year-old 
patient, who had been working with neurotoxic chemicals for many years, had gross 
neuro-urophysiological deviations. In three other patients with long lasting alcohol 
abuse, abnormal neuro-urophysiological measurements proved toxic neuropathy. 
Apart from the latter four cases, no new diagnoses were made. No patient with 
neuro-urophysiological abnormalities had unsuspected neurological or other disease 
(for example diabetes mellitus). 
According to Padma-Nathan, some type of denervation supersensitivity could be 
expected in neurologically impaired patients, with a higher frequency of neurological 
abnormalities in patients with a positive papaverine test.23 Also, Sidi et al stated that 
men with neurogenic impotence have an increased sensitivity to vasoactive 
pharmacotherapy.25 We were not able to corroborate these findings: The 17 patients 
who responded with adequate rigidity on intracavernous injection of 25 mg 
papaverine-hydrochloride had equal neurophysiological abnormalities as the 34 in 
whom 50 mg were necessary. This finding can be explained by the fact that 
denervation supersensitivity to pharmacological stimulation is a concomitant sign of 
motor-deficit impotence, whereas our study revealed sensory-deficit impotence only. 
As far as pelvic floor electromyography is a reflection of motor neuron function, the 
absence of any abnormality on electromyography studies makes motor-deficit 
impotence in our patients less likely. However, for the evaluation of motor-deficit 
impotence penile electromyography, a technique recently introduced by Wagner et 
al, seems more reliable than pelvic floor electromyography.26 
Conclusion 
Our study revealed that in patients with erectile dysfunction but no clinical signs of 
neurological disease, many more sensory disturbances were found on neuro-
urophysiological investigation than could be expected by hazard. This finding 
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suggests a causal relationship. From a clinical viewpoint, under the surface penile 
sensory disorders are much more frequent than clinicians assume from their clinical 
observations. Our study also proves that distinction should be made between 
sensory- and motor-deficit impotence. 
Fundamental research is needed to elucidate the short term and long term 
implications of the detected abnormalities. The anatomical substrate can perhaps be 
identified by histological or neurotransmitter studies on tissues of the urogenital 
system. Also the effect of environmental factors, such as smoking of cigarettes, use 
of drugs and other neurotoxic agents remains subject for further investigation. From 
a therapeutical viewpoint it seems worthwhile to investigate whether patients with 
sensory disorders have decreased plasma levels of folic acid, or vitamin B-6 or B-12. 
Such a finding would provide a rationale for pharmacological treatment. 
Whether the outcome of our comprehensive neuro-urophysiological tests has 
consequences for the therapeutic assessment of individual patients remains subject 
of further study. 
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Abstract 
In the literature, the importance of the neurologic factor in the etiology of erectile 
dysfunction in patients with diabetes mellitus is subject to much debate. This study 
reports on the findings of neuro-urophysiological investigations in impotent and 
potent diabetic patients, as well as impotent non-diabetic patients. Additionally, 
hormonal and vascular evaluation was done. 
The neurophysiological evaluations consisted of assessment of somatic as well as 
autonomic nerves, by measuring the latencies of somatosensory evoked potentials of 
the posterior tibial and pudendal nerves, and of the bulbocavernosus- and urethro-
anal reflexes. 
The results show a higher incidence of more severe neuropathy in impotent diabetic 
men. Also more frequent abnormal intracavernous pharmacotesting, suggesting 
vasculogenic impotence, was found in impotent diabetic patients. No significant 
differences for plasma testosterone and prolactin were found between the three 
groups under investigation. Significant differences occurred for plasma glucose, 
glycosylated hemoglobin, and luteinizing hormone. 
The authors conclude that diabetic sensory neuropathy plays a crucial role in the 
etiology of diabetic impotence, and that angiopathy is of secondary importance. The 
results show that poor diabetes regulation is associated with diabetic impotence. 
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Introduction 
The literature contains many controversies in respect to the etiology of erectile 
dysfunction in male patients with diabetes mellitus. In a random survey of 200 
diabetic men in 1971 Ellenberg reported a prevalence of impotence of 59 per cent.1 
In that study a neuropathic factor was held responsible in the majority of cases. 
Generally an organic cause is assumed: some authors associate diabetic impotence 
with neuropathy, whilst others underline the importance of vascular factors.2"8 Both 
hypotheses meet in the assumption that diabetic metabolic disorders cause 
angiopathy by metabolic affliction of the endothelium; this angiopathy on its turn 
causes ischemic neuropathy.6"9 Furthermore, disturbances of the hypothalamic-
pituitary-gonadal axis and dysregulation of the central autonomic nervous system 
have been reported as possible causes for impotence.10,11 
In the literature also factors such as diminished self esteem and bad disease 
acceptance have been related to impaired sexual functioning in male diabetic 
patients.12 This is underlined by the fact that Ellenberg in 1984 argued the 
importance of a neurogenic factor in the etiology of diabetic impotence and at the 
same time stressed the importance of psychologic wellbeing.13 
To clarify these different etiologic notions, we conducted neurophysiological, 
hormonal, and vascular investigations in impotent diabetic patients, and also in 
'ideal' control groups as proposed by Faerman et al.3 These control groups consisted 
of potent diabetic as well as impotent non-diabetic patients. Neurophysiological 
results in these three patient groups were compared with those obtained in 50 
healthy male volunteers with normal sexual function.14 
Patients and Methods 
For this study, male patients were assessed with insulin dependent diabetes mellitus 
(Type I). Following the recommendations of Faerman et al3, the study population 
consisted of impotent diabetic, potent diabetic and impotent non-diabetic patients. 
The impotent diabetic patients were recruited from those, who sought out urologie 
help because of complaints of erectile dysfunction. The potent diabetic controls were 
recruited from a group of responders to a call for volunteers published in a diabetes 
magazine. Hence, these patients participated voluntarily; they all reported normal 
sexual function and they all gave written informed consent to the procedure. The 
impotent non-diabetic controls were selected from a study population of 123 patients 
with complaints of erectile dysfunction and no clinical signs of neurologic disease.14 
The study protocol was approved by the ethical committee of our hospital 
(Committee Experimental Investigations on Humans, University Hospital Nijmegen; 
no. 88-002529). 
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Because in the above mentioned study on 123 impotent non-diabetic patients we 
found that sub-clinical neuro-urophysiological abnormalities are age related, for this 
study we adapted the age distributions of the impotent diabetic and impotent non-
diabetic patients to that of the potent diabetic volunteers that is all patients above 
the age of 60 years were excluded. This lead to the following composition of the 
study groups: of 38 impotent diabetic patients who visited our outpatient department 
27 were selected with a mean age of 48 years (range, 2 4 - 6 0 years) and a mean 
disease duration of 17 years (range, 5 - 36); all 30 potent diabetic patients who 
responded to the advertisement were included, they had a mean age of 44 years 
(range, 25 - 60 years) and a mean disease duration of 14 years (range, 1-35 years). 
Finally, of the 123 impotent non-diabetic patients 102 were selected with a mean 
age of 47 years (range, 24 - 60 years). The composition of the study group as a 
whole is given ш table 1. 
Table 1: Composition of the study groups 
impotent non-diabetic pis. (IND) η = 102 
impotent diabetic pis (ID) η = 27 
potent diabetic pts (PD) η = 30 
reference group, healthy male volunteers η = 50 
In all patients history was taken, with emphasis on sexual function. Apart from 
erectile function, presence of orgasm and ejaculation were noted. Vascular risk 
factors such as myocardial infarction, hypertension and presence of proliferative 
retinopathy were documented. Also smoking habits and alcohol consumption were 
recorded. Physical examination was done, paying extra attention not only to penile 
plaques and fungal balanitis, but also to diabetic ulcers and other trophic disorders 
characteristic for complications of diabetes mellitus. 
Laboratory tests consisted of the measurement of the plasma level of testosterone, 
luteinizing hormone (LH), prolactin, creatinine and glucose. Diabetes regulation 
during three months prior to the investigation was assessed by measurement of 
glycosylated hemoglobin (HbA1c). Urine samples were taken to exclude urinary tract 
infections. Post-voiding residual urine was measured by catheterization. 
In the 129 impotent patients (diabetic and non-diabetic) the contribution of vascular 
factors was evaluated by intracavernous pharmacological testing.15 To increase 
diagnostic accuracy, a negative pharmacotest was repeated once at a later 
occasion.18 
In all subjects included in this study comprehensive neuro-urophysiological tests were 
carried out in a room with a constant temperature of 25 0C. These tests consisted of 
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cortical evoked potentials and sacral reflex latency measurements using commercially 
available stimulation and registration apparatus (Nicolet Compact-4). Somatic as well 
as autonomic nerves were assessed. Neuro-urophysiological studies consisted of 
measurement of tibial evoked potential (ТЕР), pudendal evoked potential (PEP), 
bulbocavernosus reflex latency (BCR), and urethro-anal reflex latency (UAR, figure 
2, chapter 1). Cortical evoked potentials were obtained by international standards.14 
For tibial evoked potential the posterior tibial nerve was stimulated at the ankle of 
the right foot, and for pudendal evoked potential stimulation was on the dorsal 
penile nerve (a branch of the pudendal nerve). To measure bulbocavernosus reflex 
latency, the penile shaft was stimulated as in pudendal evoked potential. Recording 
was in the right ventral quadrant of the external anal sphincter muscle with a 
concentric needle electrode. To measure urethro-anal reflex latency, we stimulated 
the proximal urethra using an indwelling balloon catheter with two ring electrodes 
10 and 20 mm from the base of the balloon. After insertion into the bladder and 
filling of the balloon the catheter was retracted, allowing direct electrical stimulation 
of the urethral mucosa. This catheter enabled residual urine determination and 
warranted continuous bladder drainage during the procedure. 
On the basis of reference values found in 50 healthy male volunteers with a history 
of normal erectile potency14, we distinguished between normal and pathological 
results of the neuro-urophysiological investigations: The finding of a latency above 
the P^-percentile (reference limit) of the 50 healthy volunteers was considered 
abnormal. Non-evokability in somatosensory evoked potentials or sacral reflex 
latency measurement was also considered pathological, because this phenomenon 
was never seen in the 50 healthy volunteers. In statistical testing, these cases were 
considered to have the most deviant outcome values. 
For statistical comparison of sample percentages between the three groups the chi-
square test was used. For comparison of sample distributions in impotent diabetic 
patients with each of the two control groups the Ryan multiple F-test was used17; 
mutual comparison of two groups was done by Student's 2-sample t-test, for 
continuous variables, and with the chi-square test in case of sample percentages. 
Results 
In table 2 the distribution of age and disease duration of the study groups is 
depicted. Disease duration was similar for both potent and impotent diabetic 
patients (t-test: ρ = 0.27). In only two of the impotent diabetic patients, and in one 
of the potent diabetic patients, diabetic foot ulcers were seen. None of the patients 
suffered from diabetic gangrene, nor showed any of the diabetic patients post-
voiding residual urine at catheterization, or positive urine culture. Vascular risk 
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factors were found in 5 (19%) of the impotent diabetic patients, in 18 (18%) of the 
impotent non-diabetic patients, and in 2 (7%) of the potent diabetic patients. There 
was no significant difference in the prevalence of vascular risk factors between the 
three groups (chi-square test: ρ = 0.26). 
Table 2: Dutribution of age and disease duration (years) of the study groups 
IND 
ID 
PD 
η 
102 
27 
30 
mean 
47 
48 
44 
age 
range 
2 4 - 6 0 
2 4 - 6 0 
25 -60 
disease duration 
mean 
_ 
17 
14 
range 
_ 
5 -36 
1 -35 
The results of the laboratory tests are given in table 3. This table shows that there 
were no differences between the potent and impotent diabetic patients, except for 
HbA 1 c and plasma glucose. HbA 1 e determination indicated that diabetes regulation 
was better in the potent diabetic volunteers. Remarkably, serum luteinizing hormone 
was significantly lower in the diabetic compared to non-diabetic patients, whereas 
testosterone showed a tendency to higher levels, and prolactin to lower levels. 
Table 3: Comparison of laboratory tests between impotent non-diabetic (IND), 
impotent diabetic (ID) and potent diabetic patients (PD); laboratory 
normal values are given in parentheses 
statistical comparison 
IND - ID ID - PD 
creatinine 
(60-110 μπιοΐ/ΐ) 
glucose 
(4.0-5.5 ттоІЛ) 
HbA1e (4.2-6.3 %) 
testosterone 
(11-45 птоІЛ) 
LH 
(1.8-9.5 ІЩ) 
prolactin 
(100-700 т І Щ ) 
mean 
range 
mean 
range 
mean 
range 
mean 
range 
mean 
range 
mean 
range 
IND 
η = 
94 
6 3 -
5.4 
3.9 -
-
20.4 
1.9 -
7.9 
1.1 -
157 
4 0 -
102 
140 
6.6 
50.4 
30.0 
650 
ID 
η = 
98 
68-
13.8 
4.3 -
9.2 
6.6-
23.4 
9.0-
4.4 
139 
100 
27 
244 
24.1 
13.3 
44.8 
14.0 
- 550 
PD 
η = 
91 
6 9 -
9.2 
2.2-
7.6 
4.8-
21.1 
1.2 -
4.4 
1.6-
141 
100 
30 
126 
16.5 
10.6 
49.1 
13.0 
-640 
NS NS 
NS 
NS 
NS 
NS 
NS 
S = etabstically significant, NS - ·Ιβ1ΐ8ΐιοαΙΙν non-significant (Ryan mult]pJ*-F toa<) 
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Intracavemous pharmacotesting showed a persistent negative test in 58 per cent of 
the diabetic patients, whereas for the impotent non-diabetic patients this figure was 
30 per cent (chi-square test: ρ = 0.02). No prolonged erections or priapisms were 
seen following intracavemous pharmacological stimulation. 
Figure 1 shows the neuro-urophysiological findings in the three groups (p-values 
according to chi-square test). Statistical comparison of the neuro-urophysiological 
data of the impotent diabetic and impotent non-diabetic men shows significant 
differences for tibial evoked potential and urethro-anal reflex measurements (chi-
square test: p-values < 0.001). In these two groups the outcome of latency 
measurements involving the pudendal nerves (that is pudendal evoked potential and 
bulbocavernosus reflex) show no significant differences (chi-square test: p-values £ 
0.11). Comparison of potent and impotent diabetic patients shows that tibial evoked 
potential, bulbocavernosus reflex and urethro-anal reflex measurement was 
significantly more frequently abnormal in the latter group (chi-square test: p-values 
<, 0.001). Similar to impotent diabetic versus impotent non-diabetic patients, the 
comparison between pudendal evoked potential values of potent and impotent 
diabetic patients shows no significant differences (chi-square test: ρ = 0.11). 
Table 4 shows that in 57 diabetic patients, the occurrence of pudendal evoked 
potential as single abnormal evoked potential is very rare; in all but three patient it 
was associated with abnormal tibial evoked potential. Also the association of 
abnormal bulbocavernosus reflex with abnormal urethro-anal reflex latency is evident 
(table 5); in only one diabetic patient an isolated abnormal bulbocavernosus reflex 
was found. 
Overall results of the neuro-urophysiological measurements given in table 6 show 
that 85 per cent of the impotent diabetic patients had neurophysiological prove for 
neuropathy, whereas the potent diabetic patients and the impotent non-diabetic 
patients showed abnormalities in 40 and 44 per cent respectively. Furthermore, in 
impotent diabetic patients neuropathy seemed to be more severe: 9 out of 27 
impotent diabetic patients (33 per cent) had 3 or 4 abnormal tests. For the potent 
diabetic patients and the impotent non-diabetic patients these figures were 0 out of 
30 (0 per cent), and 10 out of 102 (10 per cent) respectively. These differences 
were statistically significant (chi-square test: ρ < 0.001). 
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Figure 1: Companson of the results of neuro-urophysiological investigations 
between impotent non-diabetic (IND), impotent diabetic (ID) and 
potent diabetic (ID) patients 
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Non-evokable responses are indicated at the top of each graph (most deviant outcome 
values). The doited lines indicate the P95-perceniile of the values found in the 50 
healthy volunteers. Percentages of abnormalities are indicated 
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Table 4: Comparison of normal and abnormal ТЕР and PEP measurements in 
102 impotent non-diabetic, 27 impotent diabetic and 30 potent diabetic 
patients 
no. of Pts. 
no. of Pts. 
no. of Pis. 
Total no. of 
abnormalities 
% 
IND 
10 
12 
8 
30 
30% 
ID 
6 
12 
1 
19 
70% 
PD 
1 
5 
2 
8 
27% 
ТЕР 
abnormal 
abnormal 
normal 
PEP 
abnormal 
normal 
abnormal 
Table 5: Comparison of normal and abnormal BCR and UAR measurements in 
102 impotent non-diabetic, 27 impotent diabetic and 30 potent diabetic 
patients 
no. of Pis. 
no. of Pts. 
no. of Pts. 
Total no. of 
abnormalities 
% 
IND 
10 
8 
12 
30 
30% 
ID 
8 
1 
8 
17 
65% 
PD 
0 
0 
4 
4 
13% 
BCR 
abnormal 
abnormal 
normal 
UAR 
abnormal 
normal 
abnormal 
Table 6: Cumulative overview of results of neuro-urophysiological testing (ТЕР, 
PEP, BCR and/or UAR) in 102 impotent non diabetic, 27 impotent 
diabetic and 30 potent diabetic patients 
IND ID PD 
no. of abnormalities 
none 
1 
2 
3 
4 
57 (56%) 
19 
16 
9 
1 
4 
7 
7 
6 
3 
(15%) 18 (60%) 
11 
1 
-
_ 
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Discussion 
The association of neuropathy and sexual dysfunction in diabetic men meets 
advocates and opponents, although mechanisms for obtaining and maintaining penile 
erection depend strongly on neurophysiological processes: Sexual stimuli of various 
origin (tactile, audio-visual, gustatory and olfactory) arouse psychological 
mechanisms, resulting in neurological impulses via somatic and autonomic motor 
tracts to urogenital effector organs. The result is relaxation of cavernous smooth 
muscle cells and an increase of arterial inflow, leading to penile tumescence and 
rigidity.18,19 Direct mechanical stimulation of penile sensory nerves and the reflex 
activation of pelvic floor muscles through motor nerves are of supportive value.20 
From this physiological review it is obvious that any disease, that afflicts penile 
nerve tracts or blood vessels, can interfere with erectile potency. In vivo and in vitro 
studies have stressed the negative impact of hyperglycemia and accumulation of 
glucose metabolites on nerve and endothelium cells.4,8,9,21"23 For this reason 
neuropathy and angiopathy can be considered to be of overriding importance in the 
etiology of erectile dysfunction in diabetic men.2"9 
This study compared biochemical, vascular and neurophysiological tests performed in 
impotent diabetic, potent diabetic and impotent non-diabetic patients. There were 
no significant age differences between the three patient groups, nor was there any 
significant difference between disease duration of the impotent and potent diabetic 
patients. Of the biochemical investigations the most striking findings were the 
significantly lower values for HbA1c and plasma glucose in the potent diabetic 
compared to the impotent diabetic patients. This indicates better regulation of 
diabetes in the former. The most striking endocrinologie findings in our study were 
the significantly lower serum luteinizing hormone levels and the somewhat higher 
testosterone levels in the diabetic patients compared to the non-diabetic patients 
(table 3). This 'hypogonadotrophic hypergonadism' has not been reported previously 
and is left without any explanation. Important, however, is the fact that in diabetic 
patients a hypogonadal state (that is low testosterone and high luteinizing hormone) 
can not be held responsible for the occurrence of erectile dysfunction in these 
patients as in a study by Murray et al.10, who reported an increase of urinary 
luteinizing hormone and diminished serum testosterone in diabetic men with organic 
impotence. 
The intracavernous pharmacological test was more frequently negative in the 
impotent diabetic compared to the impotent non-diabetic patients. This means that 
penile angiopathy plays an important role in diabetic impotence, since a negative 
intracavernous pharmacotest indicates vasculogenic impotence. 
In our study the prevalence of neuropathy was 85 per cent in the impotent diabetic 
patients. In these patients neuropathy was not only more frequent, it was also more 
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severe in comparison to potent diabetic and impotent non-diabetic patients (table 
6). This makes a causal relation between diabetic neuropathy and erectile 
dysfunction more than likely. In diabetic patients neurogenic impotence seemed of 
greater importance than vasculogenic impotence: in our study 85 per cent of the 
impotent diabetic patients had neuropathy, whereas 58 per cent had angiopathy as 
known by a negative papaverine test. These figures are supported by several 
authors, who reported 43 to 68 per cent of vasculogenic impotence in diabetic 
men*
24
, but up to 82 per cent of neurogenic impotence.1 
The results of this study wind up the discussion on the importance of a neurological 
factor in the etiology of diabetic impotence. Of the etiologic factors that are thought 
to be related to diabetic impotence, neuropathy emerged as the factor that differed 
most significantly between impotent diabetic patients and both other groups. In a 
similar study on potent and impotent diabetic patients Buvat et al came to the same 
conclusion.25 Both studies corroborate earlier finding of Ellenberg who appointed 
diabetic neuropathy as a major causal factor.1 
Several authors have discussed the issue of age and disease duration, and their 
relationship to diabetic impotence.6,12,26·27 Our study, that included potent and 
impotent diabetic patients of comparable age and disease duration, provides 
evidence that there is no such relationship. Although patients were of the same age 
and had the same disease duration, the impotent diabetic patients showed more 
frequent and more severe neuropathy. For this finding there are several possible 
explanations. Most likely, the worser regulation of the diabetes mellitus in the 
impotent patients is responsible for the more frequent and more severe neuropathy. 
Furthermore, the fact that patients of comparable age and disease duration showed 
different neurophysiological parameters -some impotent diabetic patients showed 
gross neuropathy at relatively short disease duration, whereas other potent diabetic 
patients had perfectly normal investigations after having diabetes for over 30 years-
can also mean that there is a different susceptibility to neuropathy in individual 
patients. Perhaps some diabetes patients are genetically predisposed to develop 
neuropathy and therefore become impotent. For diabetes in general a genetic factor 
is indeed assumed in its etiology.28 
The neuro-urophysiological data allow some considerations on the subject of the 
localization of neuropathy and its relation to the pathophysiology of erectile 
dysfunction in diabetic patients. Comparison of the three groups shows that 
abnormal tibial evoked potential and urethro-anal reflex are more frequently found 
in impotent diabetic patients, whereas pudendal evoked potential and 
bulbocavemosus reflex shows almost equal distributions of abnormalities (figure 1). 
Apparently, diabetes mellitus afflicts peripheral somato-sensory tibial nerves 
(reflected by tibial evoked potential) and autonomic sensory pelvic nerves (reflected 
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by urethro-anal reflex) more strongly than the somato-sensoiy pudendal nerves. This 
can be explained by the difference in neuro-anatomical structure (that is length) as 
compared to the tibial nerves.9 
Remarkable in our study was the fact that none of the diabetic patients had post-
voiding residual urine. Apparently, in these patients no relevant detrusor 
hypocontractility due to affliction of autonomic motor innervation of the urinary 
bladder was present. From a neurophysiological viewpoint, however, it could be 
expected that micturition disorders coincide with sexual dysfunctions.1,3,гя In a 
previous study we have reported on the importance of penile sensory disorders in 
the etiology of erectile dysfunction.14 In the present study we have found urogenital 
autonomic sensory neuropathy as depicted by an abnormal urethro-anal reflex in 16 
out of 27 patients (59%), in whom urogenital motor innervation seemed intact. The 
importance of urogenital sensory disorders for the etiology of impotence is 
underlined by the fact that 12 out of the 16 impotent diabetic patients (75%) with 
autonomic sensory neuropathy (abnormal urethro-anal reflex) also had somato­
sensory neuropathy (abnormal pudendal evoked potential and/or bulbocavernosus 
reflex). The frequent finding of sensory neuropathy in impotent diabetic patients 
with intact urogenital motor innervation refers to the phenomenon of sensory deficit 
impotence, that is to sexual dysfunction due to a diminished sensory input from the 
urogenital tract and consequent underactivation of sexual reflex mechanisms. The 
likelihood of penile sensory neuropathy being initially more important in the etiology 
of diabetic impotence than motor neuropathy is further supported by studies that 
have found that diabetic neuropathy initially is predominantly sensory30, and that the 
human corpus cavernosum is abundantly innervated by sensory nerves that branch 
from the dorsal penile (pudendal) nerve.3' In conclusion it can be stated that 
urogenital motor neuropathy, that generally is held responsible for diabetic 
impotence2,3, seems to be of lesser importance than sensory neuropathy. Also the 
fact that in less than half of the impotent diabetic patients a positive intracavernous 
pharmacological test was found supports our conclusion that motor neuropathy was 
not an important cause for diabetic impotence in the present study, because in cases 
of motor neuropathy a supersensitive reaction to pharmacological stimulation, and 
consequently a much higher numbers of positive pharmacological tests and/or 
prolonged erections would have been found.32 
Although the differences between the groups under investigation are striking, some 
reluctance towards the results seems appropriate. A factor like body weight has not 
been analyzed, although it might have biassed the study results, since obesity is 
reported to influence the autonomic system33. Hence, it might interfere with sexual 
function and autonomic function tests. Also the actual plasma glucose level, that was 
the highest in the impotent diabetic patients might have influenced the 
neurophysiological test results. Both autonomic regulation of the microcirculation 
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and cardiovascular reflex-mechanisms are influenced by altering plasma glucose 
levels.34'35 
We conclude that neuropathy plays a crucial role in the etiology of erectile 
dysfunction in insulin dependent diabetic males, and that this neuropathy is mainly 
sensory in nature. Furthermore, the results show that better diabetes regulation 
prevents diabetic patients from becoming impotent. Although this study bears clear 
evidence for an organic etiology for diabetic impotence, pure psychogenic erectile 
dysfunction in men with diabetes mellitus remains possible, and psychological 
problems will accompany erectile dysfunction in many patients. The latter fact is of 
utmost importance for the therapeutic assessment of the impotent diabetic man. A 
therapeutic approach that focuses on organic features only, is bound to fail. As 
diabetic impotence is a multi-factorial phenomenon -albeit mainly caused by organic 
disease- it should be treated in a multi-disciplinary team, including psychotherapists, 
andrologists, endocrinologists, urologists and general practitioners. 
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Abstract 
To date the precise etiology and nature of erectile dysfunction in men with insulin 
dependent diabetes mellitus is poorly understood. Psychological as well as organic 
factors are considered to be important; amongst organic factors vasculopathy and 
neuropathy are forwarded as the principal causes. 
To clarify the issue we conducted neuro-urophysiological investigations and color 
duplex ultrasonography in 19 impotent diabetic males and 40 impotent non-diabetic 
males. Results were compared with those obtained in healthy volunteers. 
Abnormal neuro-urophysiological tests were found in 74 per cent of the impotent 
diabetics, and in 30 per cent of the impotent non-diabetics (p = 0.02). On color 
duplex ultrasonography in none of the patients an indication for affliction of the 
penile arterial inflow tract was found. Veno-occlusive disease was made likely in 58 
per cent of the impotent diabetics and in 23 per cent of the impotent non-diabetics 
(p = 0.02). Hormonal abnormalities seemed to play an insignificant role. 
This study shows that neuropathy was the most important etiologic factor for 
impotence in diabetic males; our study also shows that this neuropathy was 
autonomic in nature. Vasculopathy was of lesser importance, and when it was found 
it was suggestive for malfunction of the veno-occlusive system. 
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Introduction 
Erectile dysfunction is a frequently encountered complication in male patients with 
insulin dependent diabetes mellitus. A prevalence of 59 per cent has been reported 
in a random survey of 200 diabetic men.1 Generally an organic etiology like 
neuropathy or vasculopathy is held responsible.2'3*5 Other authors have appointed 
disturbances of the hypothalamic-pituitaiy-gonadal axis as an important cause for 
erectile dysfunction in male diabetics.6 Apart from physical impairment, 
psychological factors obviously play an important role.7' 
In a neurophysiological study of potent and impotent diabetic as well as impotent 
non-diabetic patients we found more frequent and more severe neuropathy in 
impotent diabetics.9 In these impotent diabetics we found indications for neuropathy 
in 85 per cent, and for vasculopathy in 58 per cent. Apparently, diabetic neuropathy 
plays a crucial role in the etiology of diabetic impotence, and vasculopathy is of 
secondary importance. For this study vasculopathy was diagnosed on the basis of 
repeated negative intracavernous pharmacological tests. However, it is known that 
the diagnostic accuracy of intracavernous pharmacological tests is biassed by 
circumstantial influences such as stress and anxiety.10 Therefore, it seemed 
worthwhile to combine the outcome of neuro-urophysiological tests with a more 
accurate method for testing the functional status of the penile vascular bed, for 
example with duplex ultrasonography.11 
We herewith present the results of combined neuro-urophysiological investigations 
and color duplex ultrasonography in 19 impotent diabetic males and 40 impotent 
non-diabetic males. For both groups the neuro-urophysiological parameters are 
compared with those obtained from 50 healthy volunteers12, and the results of 
dynamic color duplex ultrasonography are compared with those obtained from 44 
healthy volunteers13. 
Patients and Methods 
For this study 19 male patients with insulin dependent diabetes mellitus (type I) and 
40 non-diabetic patients who visited our outpatient department because of 
complaints of erectile dysfunction were investigated. To avoid age-induced bias, 
patients were selected between 25 and 60 years of age. Mean age of the 19 
impotent diabetic men was 48 years (range, 2 5 - 6 0 years), for the 40 impotent non-
diabetic patients this was 46 years (range, 2 8 - 6 0 years). The study protocol has 
been described extensively in earlier reports.9·10,12·13 In all patients history was taken, 
with emphasis on sexual function: Apart from erectile function, presence of orgasm 
and ejaculation were noted. Vascular risk factors such as myocardial infarction and 
hypertension were documented. Also smoking habits and alcohol consumption were 
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recorded. At the end of the intake the clinical investigator made a judgement 
whether to his opinion the erectile dysfunction was organogenic, psychogenic or 
mixed. Physical examination was done, paying extra attention to penile plaques and 
fibrosis. 
Laboratory tests consisted of the measurement of the plasma level of testosterone, 
luteinizing hormone (LH), prolactin, creatinine and glucose. Urine samples were 
taken to exclude urinary tract infections. 
In all patients comprehensive neuro-urophysiological tests were carried out. These 
tests consisted of cortical evoked potentials and sacral reflex latency measurements 
using commercially available stimulation and registration apparatus (Nicolet 
Compact-4). Somatic as well as autonomic nerves were assessed. Neuro-
urophysiological studies consisted of measurement of pudendal evoked potential 
(PEP), bulbocavernosus reflex latency (BCR), and urethro-anal reflex latency (UAR, 
figure 2, chapter 1). Cortical evoked potentials were obtained by international 
standards. For pudendal evoked potential stimulation was on the dorsal penile nerve 
(a branch of the pudendal nerve) and registration was on the scalp at the Cz-2 
point (figure 1, chapter 1). To measure bulbocavernosus reflex latency, the penile 
shaft was stimulated as in pudendal evoked potential. Recording was in the right 
ventral quadrant of the external anal sphincter muscle with a concentric needle 
electrode. To measure urethro-anal reflex latency, we stimulated the proximal 
urethra using ring electrodes mounted on an indwelling catheter. 
Based on the reference values found in 50 healthy male volunteers with normal 
erectile potency, neuropathy was diagnosed in patients with one or more latencies 
outside the normal range (that is above the P^-percentile). For pudendal evoked 
potential the upper limit was 47 ms, for bulbocavernosus reflex this was 40 ms and 
for urethro-anal reflex this was 75 ms. Non-evokability of pudendal evoked potential, 
bulbocavernosus reflex and/or urethro-anal reflex latency measurement was also 
considered pathological, because this phenomenon was never seen in the 50 healthy 
volunteers. In statistical testing, these cases were considered to have the most 
deviant outcome values. 
For the vascular diagnostic evaluation a color duplex scanner (Toshiba SSA 270-A) 
was used. Doppler spectra and B-mode color images were obtained with a 5 MHz 
linear-агтау transducer. Doppler samples were obtained from the cavernous artery 
as proximal as possible in the infrapubic region. The Doppler angle correction 
cursor was adjusted to match the correct axis of flow. From the recorded velocity 
tracing acceleration time (AT), peak flow velocity (PFV), and end-diastolic flow 
velocity (DFV) were measured. The resistance index (RI) was calculated as {peak 
flow velocity - diastolic flow velocity} divided by {peak flow velocity}. Spectrum 
samples were taken before and after intracavernous pharmacological stimulation 
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according to a time-dependent schedule (phase 1, phase 2a-2b-2c).13 Penile arterial 
function was assessed using the mean of five measurements of acceleration time and 
peak flow velocity taken at one minute intervals during the first five minutes (that is 
phase 2a) after intracavernous administration of 12.5 mg papaverine hydrochloride. 
Veno-occlusive function was assessed using the comparison of resistance indices in 
phase 1 and phase 2c. 
Based on the reference values in 44 healthy male volunteers with normal erectile 
potency, disease of the penile inflow tract (that is arterial disease) was diagnosed in 
patients with an acceleration time equal to or over 122 ms and a peak flow velocity 
lower than 22 cm/s. Veno-occlusive disease was diagnosed if resistance index in 
phase 2c did not return to its initial value (that is RIph i e i 2 e - Rlph»» ι < 0)· ^ n ^ е 
other hand, if resistance index in phase 2c did return to its initial value, or if at 
physical examination in phase 2c adequate tumescence and rigidity was palpated 
veno-occlusive function was considered normal. 
For statistical comparison of sample distributions the Wilcoxon two-sample test (two-
tailed) was used. For the comparison of sample percentages the chi-square test was 
appropriate. If the resulting p-value is smaller than or equal to 0.05 the sample 
differences are called 'statistically significant'. 
Results 
Due to the intake criterium the age distribution was similar for the 19 impotent 
diabetics and the 40 impotent non-diabetics (p = 0.49). To the judgement of the 
clinical investigator there was a psychogenic etiology in 5 of the impotent non-
diabetics, whereas all diabetics were said to have pure organogenic erectile 
dysfunction. Of these 5 so called 'psychogenic' impotent non-diabetics one had an 
abnormal neuro-urophysiological investigation (abnormal pudendal evoked potential 
and urethro-anal reflex), and another had an indication for veno-occlusive disease 
because the resistance index in phase 2c did not return to its initial value. For the 
two groups no differences between risk factors associated with erectile dysfunction 
were found: 10 out of 19 diabetics (53%), and 22 out of 40 non-diabetics (55%) 
were cigarette smokers (p-value, 0.78). In 4 diabetics (21%) and in 8 non-diabetics 
(20%) a history of cardio-vascular disease such as myocardial infarction and 
hypertension was found (p = 0.67). 
Table 1 shows the outcome of the neuro-urophysiological measurements in the two 
groups. This table shows that there were no differences between impotent diabetics 
and impotent non-diabetics for pudendal evoked potential and bulbocavemosus 
reflex measurement, urethro-anal reflex measurement, on the other hand, was 
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significantly more frequently abnormal in the impotent diabetics. In 28 of 40 non-
diabetics (70%) a completely normal neuro-urophysiological investigation was found, 
whereas only 5 of 19 impotent diabetics (26%) showed no neuro-urophysiological 
sign of neuropathy (p = 0.018). 
Table 1: Numbers of neuro-urophysiological abnormalities in 19 impotent 
diabetic (ID) and 40 impotent non-diabetic (IND) patients 
ID IND p-value 
PEP 4 (21%) 9 (23%) 1.00 
BCR 5 (26%) 3(8%) 010 
UAR 11 (61%) 5 (13%) 0003 
Table 2 shows the outcome of the color duplex ultrasonography in the two groups. 
From this table it can be concluded that according to the upfront definition of 
duplex ultrasonographic parameters indicative for arterial disease (that is AT > 122 
m/s and PFV < 22 cm/s) not one patient fulfilled this criterium. On the other hand, 
table 2 clearly shows that arterial function is significantly impaired in the diabetic 
patients. 
Table 2: Color duplex ultrasonographic parameters obtained before (phase 1) 
and during 5 minutes after (phase 2a) intracavemous pharmacological 
stimulation 
ID IND p-value 
0 028 
0 007 
0019 
AT = асссісгаіюп lime, PFV = peak (low velocity, DFV = diastolic flow velocity 
Using resistance index and clinical examination and palpation, veno-occlusive disease 
was diagnosed in 11 out of 19 diabetic patients (58%), and in 9 out of 40 non-
diabetic patients (23%). This difference was statistically significant (p = 0.017). 
AT phase 2a 
PFV phase 2a 
DFV phase 2a 
mean 
median 
range 
mean 
median 
range 
mean 
median 
range 
78 
72 
40 • 
35 
30 
14 • 
10 
10 
0 -
 104 
 65 
26 
69 
66 
44 • 
57 
51 
15 • 
18 
14 
2 -
 109 
175 
72 
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Table 3 shows an overview of the combined outcome of neuro-urophysiological 
investigations and color duplex ultrasonography in both the impotent diabetic and 
impotent non-diabetic patients. The most striking finding was that in 9 impotent 
diabetic patients (47%) the combination of neuropathy and veno-occlusive disease 
was found, whereas for the impotent non-diabetic patients this was in only 3 
patients (16%). On the other hand, a completely normal diagnostic evaluation was 
encountered in 3 diabetics (16%) and in 22 non-diabetics (55%). 
Table 3: Overview of the combination of the outcome of neuro-urophysiological 
investigations (NUPHI) and color duplex ultrasonography 
ID 
IND 
veno-occlusive disease 
abnormal 
9 (47%) 
3 ( 8%) 
NUPHI 
normal 
2 (11%) 
6 (15%) 
no vascular abnormality 
abnormal 
5 (26%) 
9 (23%) 
NUPHI 
normal 
3 (16%) 
22 (55%) 
Table 4 gives an overview of the laboratory findings in both groups (laboratory 
normal values in parentheses). This table shows that there are no statistical 
differences between the laboratory findings of impotent diabetics and impotent non-
diabetics. In individual diabetic patients we found only minimal abnormalities: There 
was 1 diabetic and 1 non-diabetic with an elevated plasma creatinine suggesting 
renal failure, and 1 non-diabetic with an elevated plasma luteinizing hormone but 
with normal plasma testosterone. 
Table 4: Comparison of laboratory tests between impotent diabetic (ID) and 
impotent non-diabetic patients 
creatinine 
(60-110 μπιοΙΊ) 
testosterone 
(11-45 шпоІЛ) 
LH 
(1.8-9.5 IU/1) 
prolactin 
(100-700 тШЛ) 
mean 
range 
mean 
range 
mean 
range 
mean 
range 
ID 
η = 19 
101 
78-244 
24.4 
10.0 - 44.8 
3.6 
1.8 - 5.9 
144 
100 - 550 
IND 
η = 40 
94 
69 - 126 
21.0 
1.9 - 45.5 
4.3 
1.2 - 19.9 
151 
100 - 570 
p-value 
0.83 
0.33 
0.72 
0.32 
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Discussion 
The combination of tests for the diagnosis of neuropathy and vasculopathy in 
impotent diabetic and impotent non-diabetic men yields remarkable results. In 74 
per cent of the impotent diabetics neuropathy was found on neuro-urophysiological 
investigation. For the impotent non-diabetics this was in only 30 per cent. Although 
both groups of patients showed no differences in age distribution or in the 
prevalence of risk factors such as cigarette smoking, hypertension or myocardial 
infarction, neuropathy was significantly more frequent in the diabetic patients. The 
same differences were found on investigation by color duplex ultrasonography of the 
veno-occlusive system: 58 per cent of the impotent diabetics had an indication for 
veno-occlusive disease, whereas for the impotent non-diabetics this was only in 23 
per cent. Disease of the arterial inflow tract was diagnosed neither in the diabetic 
nor in the non-diabetic patients. 
Our findings allow several conclusions on the subject of the etiology of diabetic 
erectile dysfunction as well as erectile dysfunction in general. Opposite to the 
findings of Lehman and Jacobs3, who reported that occlusion of the inflow tract was 
the most prevalent abnormality in impotent diabetics, we found that neuropathy is 
strongly associated with erectile dysfunction in diabetic men. This is even more 
surprising since several authors have reported that diabetic neuropathy is caused by 
affliction of the vasa nervorum and therefore is secondary to angiopathy.14,15,16 From 
this it would be expected that vasculopathy is the first and most important etiologic 
factor in diabetic impotence. 
From our neuro-urophysiological data it is obvious that diabetic neuropathy is 
primarily autonomic in nature. We found no significant differences for somatic nerve 
tests (pudendal evoked potential and bulbocavernosus reflex) between impotent 
diabetics and non-diabetics. Lin and Bradley reported comparable results.17 Testing 
of autonomic sensory nerves (urethro-anal reflex) revealed significantly more 
frequent neuropathy in the diabetics as compared to the non-diabetics (table 1). 
Our color duplex ultrasonographic data prove that affliction of the arterial inflow 
tract is of minor importance in both diabetogenic and non-diabetogenic erectile 
dysfunction. In all patients, diabetic and non-diabetic, arterial function appeared to 
be adequate although it was significantly more impaired in the diabetic patients 
(table 2). 
The small importance of affliction of the arterial inflow-tract, as suggested by our 
data, questions the basis of arterial revascularisation procedures in diabetic men with 
erectile dysfunction. Our study proves that vasculogenic erectile dysfunction in 
diabetes is primarily due to veno-occlusive dysfunction rather than to inflow-tract 
affliction. According to the findings of other authors this might be due to 
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degeneration of connective tissues of the corpora cavernosa and the tunica 
albugínea18 or to affliction of the cavernosal endothelium10, or to impainnent of 
both. 
Probably, veno-occlusive dysfunction is less frequent than reported in the results, 
because in no less than 33 per cent of the 44 healthy volunteers the resistance index 
in phase 2c failed to return to its initial value. Hence, in these healthy volunteers 
the actual outcome of the vascular diagnostic evaluation fulfilled the definition of 
veno-occlusive disease, despite the fact that these were potent volunteers. This is 
attributed to psychogenic inhibition, that on its turn causes diminution of cavernous 
smooth muscle relaxation and, therefore, veno-occlusive malfunction. In regard to 
our patient population this means that real veno-occlusive disease due to endothelial 
or emissary veins dysfunction was even less than the 23 per cent as found in the 40 
non-diabetics and less than 58 per cent as was found in the 19 diabetics. Therefore, 
the role of vascular disease in the etiology of erectile dysfunction in diabetic males 
is even attenuated. 
Finally, from our data it must be concluded that hormonal abnormalities are of 
minor importance in the etiology of erectile dysfunction in the diabetic. 
Another remarkable finding of this study was the fact that in 3 out of 19 impotent 
diabetics a completely normal neurovascular evaluation was found. This suggests a 
psychogenic etiology in these patients although they were classified as 'pure 
organogenic'. On the other hand, 2 out of 5 'pure psychogenic' impotent non-
diabetic patients showed clear abnormalities on neuro-vascular diagnostic evaluation. 
From this it must be concluded that based on history taking the judgement of the 
clinical investigator with respect to the etiology of erectile dysfunction is of limited 
value in individual patients. Our data show that objective neuro-vascular parameters 
can differ importantly from the subjective judgement of an experienced physician. 
Therefore, patients who present with complaints of erectile dysfunction should be 
submitted to a comprehensive neuro-vascular diagnostic work up. For this purpose 
we recommend the combination of neuro-urophysiological testing and dynamic color 
duplex ultrasonography as presented in this study. 
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Abstract 
Although neurophysiological techniques have become widely accepted in the 
diagnostic evaluation of urogenital tract dysfunction, arguments have been forwarded 
to question their validity. Current techniques merely deal with somatic sensory 
nerves, whereas micturition and sexual functions depend on autonomic motor nerve 
function as well. This study presents a new technique of motor evoked potentials 
obtained after magnetic stimulation of the cauda equina. Bladder and pelvic floor 
motor evoked potentials could be measured with concentric needle electrodes. Mean 
latency was 35.6 ms for bladder-motor evoked potential and 10.6 ms for pelvic floor-
motor evoked potential. The technique was easy to perform, and provided consistent 
and objective data. No harmful side effects were noted. 
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Introduction 
Neurophysiological investigatory techniques for the evaluation of lower urinary tract 
dysfunction have become widely accepted, and their usefulness is universally 
recognized.1,2 Determination of sacral reflex latency time after stimulation of 
pudendal nerves was proved to be useful as "the Urologist's Knee Jerk".3 
Measurement of cortical evoked potentials derived from both somatic and visceral 
sacral nerves was introduced into urological practice in the early 1980s.4* 
Besides these more classical neurophysiological techniques, other testing modalities 
have been proposed: measurement of urethral mucosa sensory threshold, cutaneous 
thermal threshold, and vibration threshold.7"9 Despite the common confidence in the 
usefulness of current neurophysiologic tests, some authors have questioned their 
validity.8,10,11 A possible explanation for the shortcomings of the aforementioned 
tests is that they mainly investigate sensory neural pathways. Therefore, the outcome 
of these tests will only reflect part of the functional status of urogenital tract 
innervation. Another serious constraint is that they deal with somatic nerves only, 
whereas micturition and sexual functions depend on autonomie nerve function as 
well.12 
In regard to these constraints, it is obvious that an objective method for 
investigation of somatic and autonomic motor innervation of the urogenital tract 
would be a most welcome addition to the diagnostic armamentarium in 
neurourologica] practice. 
In the recent past several propositions have been made to lessen the drawbacks of 
current neurophysiological investigatory techniques. Recently, a method for 
evaluation of the electrical activity of smooth muscles of the penile corpora 
cavernosa was introduced.13 This seems to be a most promising method of 
investigating autonomic penile motor nerves. The objectivity of this method, as well 
as it's clinical applicability, have yet to be proved. 
Others have reported on methods for neurophysiological evaluation of central and 
peripheral somatomotor neural pathways after electrical or magnetic stimulation. 
Merton and Morton described the measurement of motor evoked potentials by 
cortical stimulation with high voltage shocks.14 Problems with patient discomfort and 
pain seemed to be solvable.15 A method of magnetic stimulation of neural tissues 
was even more promising.16 A strong and brief current was passed from a high 
voltage capacitor system through a coil, generating a time varying magnetic field. 
Application of the coil on the appropriate part of the cerebral cortex induced limb 
movement without causing distress or pain. Thus, motor conduction time could be 
measured easily. 
Several authors used this technique of cortical magnetic stimulation for investigation 
of the pelvic floor muscles.17,18 Opsomer et al reported on pelvic floor motor 
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evoked potentials after magnetic stimulation of sacral roots. In 15 healthy male 
volunteers they found a mean peripheral motor conduction time of 7.2 ms (standard 
deviation, 1.0 ms).17 
To date, no study has described a neurophysiologic technique for unequivocal and 
objective evaluation of motor innervation of the human bladder. The present study 
describes a new and simple method for measuring motor evoked potentials from the 
bladder using magnetic stimulation of the cauda equina. 
Patients and Methods 
For this study 12 selected women were investigated. Mean patient age was 38 years 
(range, 21 - 56 years). Patients were admitted to our neurourological unit for 
comprehensive diagnostic screening of the micturition disorders. Only patients with 
urodynamically proved detrusor hyperreflexia were included in this study, because 
patients with intact sensory and motor innervation of the bladder seemed most 
suited for neuro-urophysiological evaluation of autonomic bladder innervation. A 
total of 6 patients suffered from multiple sclerosis, 3 had detrusor instability in the 
absence of a known neurological disease, and 3 had a complete (motor and sensory) 
spinal cord lesion due to trauma. Therefore, none of these patients was likely to 
suffer from peripheral neuropathy. Except for the three patients with detrusor 
instability of unknown origin, the other patients had a neurologically proved lesion 
of the upper motor neuron and/or pyramidal tract. 
There was no contraindication (that is cardiac pacemaker or epilepsy) to magnetic 
stimulation. After explanation of the purpose of the magnetic stimulation procedure, 
all patients gave informed consent to the investigation. 
Stimulation and registration was done with commercially available equipment 
(Nicolet Compact-4, Magstim 200). For magnetic stimulation a coil with a diameter 
of 90 mm was used, producing a magnetic field strength of maximal 1.5 T. Stimulus 
adjustment was possible on a zero to hundred percent scale. Stimuli were given over 
the inter-vertebral space of L4 - L5, with the patient in the supine position lying on 
the coil. In most patients slight to and fro movement of the coil was necessary 
before clear motor evoked potentials could be measured. After correct positioning 
of the probe stimulus thresholds were determined by increasing the stimulus 
intensity gradually with increments of 10%, starting from 10% of the maximal output 
of the stimulator. 
Recording was done consecutively in the external anal sphincter and in the bladder 
wall with concentric needle electrodes (Dantec). Motor evoked potentials from the 
bladder wall were recorded with a needle electrode mounted on a ureteral stent 
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(external diameter, 6 F). This modified stent was passed through a transurethrally 
inserted open end steel tube (internal diameter, approximately 6 F). First, the 
bladder was emptied completely. Since the entire process of obtaining the bladder 
motor evoked potential tracings took no more than a few minutes, renewed bladder 
filling could not interfere with the measurement nor could it cause needle 
displacement. After insertion the tube was pressed firmly against the bladder dome, 
and without any possibility of kinking the stent was pushed forward until mucosal 
penetration of the needle electrode was felt. Too deep insertion (that is perforation 
of the bladder wall) was prevented by allowing only 5 mm of the needle pierce 
through the tip of the stent (figure 1). The sizeable difference in diameter of needle 
and stent warranted a maximal penetration dept of 5 mm. The steel tube was fixed 
to the left labium with plaster to prevent retraction of the stent or movement 
artifacts. 
Figure 1: modified ureteral stent with mounted needle electrode (magnification); 
abo the open end steel tube is shown 
Electromyographic activity was recorded with a one-channel electromyography 
recorder. In all patients, we recorded the electromyographic activity of the anal 
sphincter at rest and, if possible, at voluntary contraction, to examine needle 
localization. Sensitivity of the amplifier varied from 0.5 to 2.5 mV for pelvic floor 
muscle activity. For detrusor muscle activity amplifier sensitivity varied from 0.05 to 
1 mV. The low band-pass filter setting was at 1 Hz, and the high band-pass filter 
setting was at 10 kHz. To diminish the influence of electrical activity generated by 
body movement due to the magnetic pulse or by remote striated muscle activity 
(levator ani, pelvic floor, and abdominal wall), measurements were repeated with a 
low band-pass filter setting at 100 Hz. A self-adhesive strap grounding electrode, 
soaked in a saline solution, was wrapped around the right upper thigh. 
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In each patient measurements of pelvic floor motor evoked potentials and bladder 
motor evoked potentials were repeated at least 4 times at a stimulus strength of 
100% of the maximal output. Only recordings of consistent and repeatable motor 
evoked potentials were considered acceptable for further evaluation. In cases where 
there was a response in the anal sphincter only, the procedure of intravesical needle 
placement was repeated. 
For more classical evaluation of the functional status of the urogenital tract 
innervation, we also measured bulbocavernosus-reflex latency in all patients. 
bulbocavemosus reflex latency yields information on pudendal sensory and motor 
nerves. Furthermore, we evaluated whether combining of bulbocavemosus reflex 
latency with pelvic floor motor evoked potential would enable localization studies, 
because the former comprises the complete pudendal reflex arc, whereas the latter 
only reflects the motor part. For bulbocavemosus reflex measurement, the pudendal 
nerve was stimulated over the clitoris using bi-polar surface electrodes, with the 
cathode proximal to the anode. Recording was in the external anal sphincter muscle 
with the aforementioned concentric needle electrode. A total of 8 separate latency 
measurements were recorded with single supramaximal square-wave stimuli of 60 
mA (stimulus duration, 0.2 ms). 
Results 
In all patients this technique was easy to perform and it provided results which were 
unequivocally interpretable (figure 2*°). Magnetic stimulation as described in our 
study was painless. In our experience, patient anxiety was minimised by adequate 
information and instruction. Insertion of the needle electrodes caused minimal 
discomfort. Except for the patients with a spinal cord lesion, the moment of 
penetration of the needle into the bladder wall could be indicated clearly. This 
proved to be helpful to determine correct needle placement. After correct 
positioning of the stimulation probe, repeatable and consistent responses could be 
obtained from the bladder wall, and the pelvic floor muscles. The latency times are 
given in table 1. 
In 2 patients with multiple sclerosis (WL and ЕЕ, table 1), and in 1 with a 
traumatic cord lesion (AS), we were unable to measure bulbocavemosus reflex 
latency, and in 1 of these (WL) we also failed to measure pelvic floor motor evoked 
potential latency. Bladder motor evoked potentials were measured successfully in all 
patients. 
For both pelvic floor and bladder motor evoked potentials there was a stimulus 
threshold, below which no response could be seen. Generally, the threshold for 
bladder motor evoked potentials was about 20% higher than for pelvic floor motor 
evoked potentials. 
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Table 1: Latenq/ rimes of bulbocavemosus reflex (BCR), and motor evoked 
potenriaL· (МЕР) of the pelvic floor and bladder wall 
patient 
FK 
SF 
AS 
FB 
FW 
MK 
KV 
WH 
JP 
WL 
CS 
ЕЕ 
age 
24 
35 
43 
38 
44 
31 
34 
43 
21 
38 
56 
45 
sex diagnosis 
traumatic cord lesion L-l 
traumatic cord lesion Th-5 
traumatic cord lesion Th-8 
detrusor instability uo 
detrusor inslabihty uo 
detrusor instability uo 
multiple sclerosis 
multiple sclerosis 
multiple sclerosis 
multiple sclerosis 
multiple sclerosis 
multiple sclerosis 
BCR 
37.8 
31.8 
ne 
62.0 
56.6 
21.6 
39.9 
27.3 
28 8 
ne 
28.5 
ne 
pelvic floor 
МЕР 
9.2 
11.5 
8.1 
20.0 
8.8 
10.0 
8.4 
6.6 
14 0 
ne 
5.6 
14.4 
bladder 
МЕР 
37.0 
45.7 
38.4 
32.5 
49.6 
37.0 
29.0 
32.8 
43.8 
27 4 
26.6 
28.1 
(uo = unknown origin, n« - non-«vokable) 
In some patients, a further increase in the stimulus intensity after the initial 
appearance of a bladder motor evoked potential caused increment of the amplitude 
of the motor evoked potential as well as shortening of the latency. In one patient 
we found that at a certain stimulus level (70 to 80% of the maximal output of the 
stimulator) further increase in stimulus intensity caused no further increase in 
amplitude or decrease in latency. Pelvic floor motor evoked potential latencies 
varied form 5.6 ms to 20.0 ms (mean, 10.6 ms), whereas bladder motor evoked 
potential latencies varied from 26.6 ms to 49.6 ms (mean, 35.6 ms). No clear 
correlation was found between pelvic floor motor evoked potential and bladder 
motor evoked potential latencies (Spearman correlation coefficient, ρ = 0.67). 
Elevation of the low band-pass filter setting from 1 to 100 Hz altered the shape of 
the curve, but it did not influence the latency time. Obviously, distant phenomena 
such as body movement or striated muscle activity, which are a possible cause for 
measurement artifacts, do not influence the results. No complications were noted 
and no patient had a urinaiy tract infection or hematuria after the procedure. 
In 5 of 12 patients we found an abnormal bulbocavemosus reflex latency: 1 had a 
low localization of a traumatic spinal cord lesion (AS), 2 had detrusor instability of 
unknown origin (FB and FW), and 2 had multiple sclerosis (WL and ЕЕ). Only 
minimal correlation was found between bulbocavemosus reflex and pelvic floor 
motor evoked potential latency (Spearman correlation coefficient, ρ = 0.16). 
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Figure 2: Motor evoked potentiab in 3 female patients; arrows indicate moment 
of onset of the response (upper, pt. SF; middle, pt. ЕЕ; lower, pt JP) 
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Discussion 
We report an objective technique for neurophysiological investigation of autonomic 
motor innervation of the human bladder. With a simple method of magnetic 
stimulation of the cauda equina and intravesical registration with a concentric needle 
electrode, it was possible to collect objective data on autonomic motor nerve 
function in patients with urodynamically proved intact motor innervation of the 
bladder. 
To date, neurophysiological studies of motor nerve function have evaluated the 
somatic nervous system only. Combining our technique with the measurement of 
motor evoked potentials from the pelvic floor muscles, it is possible to investigate 
somatic and autonomic motor nerve function of the urogenital tract with minimal 
invasiveness and little discomfort to the patient. 
We found sizeable spreading in the latencies measured for both pelvic floor motor 
evoked potentials and bladder motor evoked potentials. This probably is due to the 
diversity of our patient population, which included patients with possible conus 
medullaris involvement (multiple sclerosis, spinal injury). 
In the future it will be necessary to apply this technique in healthy volunteers for 
reference values. For determination of reproducibility of the technique, it will be 
necessary to repeat measurements in individual patients on different occasions. 
Repeatability of pelvic floor motor evoked potentials and bladder motor evoked 
potentials within one session proved to be good. Generally, we found the latency for 
bladder motor evoked potential (mean, 35.6 ms; range, 26.6 - 49.6 ms) to be 2 to 4 
times pelvic floor motor evoked potential latency (mean, 10.6 ms; range, 5.6 - 20.0 
ms). These differences are due to different physiological characteristics of bladder 
and pelvic floor motor nerves: bladder motor nerves consist of pre-ganglionic slow 
conducting myelinated fibres (B-type) and post-ganglionic slow conducting 
unmyelinated fibres (C-type). Pelvic floor motor nerves, on the other hand consist of 
fast conducting myelinated fibres (A-type).19 
The differences in pelvic floor and bladder motor evoked potential latencies are also 
due to the synaptic delay in the intramural (parasympathetic) ganglion cells. 
The fact that in some patients there was a clear stimulus threshold, and the fact 
that increased stimulus strength to a certain limit caused shortening of the latency 
and increase of the amplitude, both imply that we were measuring physiological 
responses. The unchanging latencies after elevation of the lower band pass filter 
setting support the assumption that our responses were actually derived from the 
bladder wall. From our study, as well as from the literature20, it seems clear that the 
signals registered by the intravesical concentric needle electrode originate from the 
bladder wall and not from adjacent structures. Therefore, it can be concluded that 
this technique provides artifact free data on parasympathetic nerve function. 
по 
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Opsomer et al found a mean latency for pelvic floor motor evoked potential of 7.2 
ms (standard deviation, 1.0 ms).17 Comparison of these results with ours shows that 
we generally found longer latencies (mean, 10.6 ms; standard deviation, 4.1 ms). The 
reason for this difference is unclear. Perhaps it is due to patient selection, since 
Opsomer et al conducted their study in healthy male subjects. Males probably have 
pudendal nerve fibres of larger diameter and, therefore, faster conduction velocities. 
Our study, on the other hand, was done on women patients with various kinds of 
neurological impairment of which the influence on motor neuron function was 
uncertain. Also, the fact that Opsomer et al used stronger stimuli (up to 2.5 T) 
might account for the shorter latencies. More powerful stimulation recruits more 
nerve fibres and widens the range of the magnetic pulse field, which in turn causes 
more distal nerve stimulation. 
The finding of an abnormal bulbocavernosus reflex latency in S of 12 patients was 
remarkable. The presence of a pelvic floor motor evoked potential in 4 of these 5 
patients with an abnormal bulbocavernosus reflex suggests that in these patients the 
pudendal lesion was localized in the sensory pathway or in the spinal interneurons, 
as can be found in patients with low localised spinal cord lesions, or in multiple 
sclerosis patients.21 This might also explain the bothersome finding of the 
combination of non-evokable bulbocavernosus reflexes and present pelvic floor 
motor evoked potentials in two patients (AS and ЕЕ). Apparently, direct stimulation 
of pudendal motor nerve fibres is possible in some patients, in whom reflex 
activation via pudendal sensory nerves and interneurons is impaired. Affliction of 
pudendal afférents and/or spinal interneurons also might account for the minimal 
correlation between bulbocavernosus reflex and pelvic floor motor evoked potential, 
as was found in our study 
The lack of correlation between pelvic floor motor evoked potential and bladder 
motor evoked potential suggests that somatic neuropathy is distinguishable from 
autonomic neuropathy, and that an abnormal somatic nerve test does not imply an 
abnormal autonomic test. This is well in accordance with our earlier finding that 
bulbocavernosus reflex latencies did not correlate with urethro-anal reflex latencies.22 
Conclusion 
Although the technique of magnetic stimulation of the cauda equina and registration 
of bladder motor evoked potentials needs further investigation, our study proves that 
with this simple technique it is possible to obtain objective and repeatable data on 
the functioning of the autonomic nervous system innervating the bladder. It seems to 
be a useful addition to other neurophysiological tests. In the future it might even 
surpass classical neurophysiological investigations. 
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An obvious subject of further investigation is the evocation of bladder motor evoked 
potentials after cortical magnetic stimulation. 
Acknowledgements 
Wim A.G.J. Lemmens, Department of Medical Statistics, assisted with the data 
management. 
Jan Helmer and Edsko Hekman, Department of Mechanical Assistance, designed 
and built the prototypes and definite version of the intravesical needle electrode. 
112 Chapters 
References 
1 Bradley, W.E., Timm, G.W., Rockswold, G.L. and Scott, F.B.: Detrusor and 
urethral electromyelography. J. Urol., 114:891, 1975. 
2 Krane, R.J. and Siroky, M.B.: Studies on sacral-evoked potentials. J. Urol., 
124:872, 1980. 
3 Galloway, N.T.M., Chisholm, G.D. and Mclnnes, Α.: Patterns and 
significance of the sacral evoked response (the Urologist's Knee Jerk). Br. J. 
Urol., 57:145, 1985. 
4 Haldeman, S., Bradley, W.E., Bhatia, N.N. and Johnson, B.K.: Pudendal 
evoked responses. Arch. Neurol., 39:280, 1982. 
5 Badr, G.G., Fall, M., Carlsson, C, Lindström, L., Friberg, S. and Ohlsson, 
В.: Cortical evoked potentials obtained after stimulation of the lower urinary 
tract. J. Urol., 131:306, 1984. 
6 Opsomer, R.J., Guérit, J.M., Wese, F.X. and Van Cangh, P.J.: Pudendal 
cortical somatosensory evoked potentials. J. Urol., 135:1216, 1986. 
7 Powell, P.H. and Feneley, R.C.L.: The role of urethral sensation in clinical 
urology. Br J. Urol., 52:539, 1980. 
8 Fowler. J.F., Ali, Ζ., Kirby, R.S. and Pryor, J.P.: The value of testing for 
unmyelinated fibre, sensory neuropathy in diabetic impotence. Br. J. Urol. 
61:63, 1988. 
9 Opsomer, R.J., Abi Aad, Α., Jamart, J., Guérit, J.M. and Van Cangh, P.J.: 
Vibratory and electrical sensibility thresholds in adults and children. 
Neurourol. Urodyn., 8:322, 1989. 
10 Desai, K.M., Dembny, K., Morgan, H., Gingell, J.C. and Prothero, D.: 
Neurophysiological investigation of diabetic impotence. Are sacral response 
studies of value? Br. J. Urol., 61:68, 1988. 
11 Lavoisier, P., Proulx, J., Courtois, F. and De Carufel, F.: Bulbocavernosus 
reflex: its validity as a diagnostic test of neurogenic impotence. J. Urol., 
141:311, 1989. 
12 Bradley, W.E.: Physiology of the Urinary Bladder. In: Campbell's Urology. 
Edited by P.C. Walsh. Philadelphia: W.B. Saunders Co., vol. 1, chapt. 4, pp. 
129-185, 1986. 
13 Wagner, G., Gerstenberg, T. and Levin, R.J.: Electrical activity of the corpus 
cavernosum during flaccidity and erection of the human penis: a new 
diagnostic method? J. Urol., 142:723, 1989. 
14 Merton, P.A. and Morton, H.B.: Stimulation of the cerebral cortex in the 
intact human subject. Nature, 285:227, 1980. 
15 Rossini, P.M., Caramia, M.D. and Zarola, F.: Mechanisms of nervous 
propagation along central motor pathways: Non-invasive evaluation in 
healthy subjects and in patients with neurological disease. Neurosurg., 
20:183, 1987. 
16 Barker, A.T., Jalinous, R. and Freeston, I.L.: Non-invasive magnetic 
stimulation of human motor cortex. Lancet, 1106, 1985. 
17 Opsomer, R.J., Caramia, M.D., Zarola, F., Pesce, F. and Rossini, P.M. : 
Neurophysjological evaluation of central-peripheral sensory and motor 
pudendal fibres. Electroencephal. Clin. Neurophysiol., 74:260, 1989. 
18 Eardley, I., Nagendran, K., Kirby, R.S. and Fowler, C.J.: A new technique 
for assessing the efferent innervation of the human striated urethral 
sphincter. J. Urol., 144:948, 1990. 
Motor evoked potentials from the urinary bladder 113 
19 Landon, D.N.: The peripheral nerve. London: Chapman and Hill, 1976. 
20 La Joie, W.J., Cosgrove, M.D. and Jones, W.G.: Electromyographic 
evaluation of detrusor muscle activity in relation to abdominal muscle 
activity. Arch. Phys. Med. Rehabil., 57:382, 1976. 
21 Bemelmans, B.L.H., Van Kerrebroeck, Ph.E.V., Hommes, O.R., Lemmens, 
W.A.J.G. and Debruyne, F.M.J.: Evidence for early lower urinary tract 
dysfunction in clinically silent multiple sclerosis. Results of comprehensive 
neurourodynamic testing in 40 patients. J. Urol., 145:1219, 1991. 
22 Bemelmans, B.L.H., Meuleman, E.J.H., Anten, B.W.M., Doesburg, W.H., 
Van Kerrebroeck, Ph.E.V. and Debruyne,F.M.J.: Penile sensory disorders in 
erectile dysfunction. Results of a comprehensive neuro-urophysiological 
diagnostic work up in 123 patients. J. Urol., 146:777, 1991. 

Chapter 9 
CRITICAL APPRAISAL OF PENILE ELECTROMYOGRAPHY 
Neurophysiologic investigations of the electrical activity 
of cavernous smooth muscles 
Bart LH. Bemelmans, Eric J.H. Meuleman, E.L Koldewijn 
Servaas LH. Notermans and Frans M.J. Debruyne 
Submitted for Publication in the International Journal of Impotence Research 
116 Chapter 9 
Abstract 
For the evaluation of neurogenic impotence neuro-urophysiological techniques such 
as somatosensory evoked potentials and sacral reflex latencies have been used. 
These techniques yield information on penile sensory innervation. Until recently, 
however, the algorithm for the diagnostic evaluation in patients with complaints of 
erectile dysfunction was lacking a technique for the evaluation of penile motor 
innervation and for the diagnosis of cavernous autonomic neuropathy and cavernous 
smooth muscle dysfunction. Recent studies of penile electromyography ('penis-
EMG') claim to fill this gap. We have tried to apply this technique in 40 patients 
with erectile dysfunction. Unfortunately we were not able to corroborate earlier 
reprarts by other authors. Our studies seem to indicate that the electrical activity 
measured in the cavernous bodies does not reflect any physiological phenomenon 
within the penis. No relation between 'penis-EMG' and penile flaccidity or rigidity 
was found. Our results prove the high susceptibility of the technique for bias caused 
by remote muscle activity or intracavernous pressure rise. We conclude that 
although the idea of penile electromyography is physiologically sound, more research 
is needed to discriminate fact and artifact and to clarify the implications of the 
signals that are measured. 
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Introduction 
During the past two decades concepts and understanding of neurogenic impotence 
have undergone important changes. Until the early 1970s the history of neurological 
disease, surgical intervention in the pelvis or metabolic disturbances in a patient with 
complaints of erectile dysfunction sufficed for the conclusion of the impotence being 
neurogenic. The introduction of sophisticated neuro-urophysiological investigatory 
techniques such as measurement of Pudendal Evoked Potential (PEP), 
Bulbocavernosus Reflex (BCR) and Urethra Anal Reflex (UAR) paved way for 
more precise and detailed neurological evaluation of the functional status of the 
urogenital tract and localization of neurological lesions. Thus, peripheral and central, 
as well as sacral and supra sacral lesions can be distinguished with the restriction 
that autonomic motor pathways cannot be assessed. In a comprehensive neuro-
urophysiological study of 27 impotent diabetics we did not find neuropathy in 15 per 
cent, whereas in 123 men with complaints of erectile dysfunction and no overt 
neurologic disease we found important age related sensory neuropathies in 47 per 
cent.1,2 Therefore, these studies only partly confirm the old pathophysiological 
concepts: neuro-urophysiological investigations prove not only to be normal in 
patients with obvious neurological or metabolic disease but also detect abnormalities 
in unsuspected patients. 
The ideal neuro-urophysiological investigatory technique would be one that 
objectively and quantitatively evaluates the functional status of all parts of the 
neurological network involved in obtaining and maintaining penile erection. The 
aforementioned techniques merely investigate penile sensory pathways. Application 
of these measurements in patients with erectile dysfunction have emphasized the 
importance of sensory deficit impotence as a distinct entity amongst the various 
possible causes for impotence. The completion of the neuro-urophysiological 
diagnostic armamentarium in the sense of techniques to evaluate the autonomic 
motor innervation of the urogenital tract has been initiated by Gerstenberg and 
Wagner, who recorded a cavernous electromyogram (penis-EMG)3,4: By means of a 
needle electrode introduced in the cavernous body a baseline intermittent firing 
activity is recorded. After audio-visual sexual- and/or pharmacological stimulation 
with increasing tumescence and rigidity a decrease of cavernous smooth muscle 
activity is noted. Only recently, single potential analysis of cavernous electric activity 
(SPACE) has been introduced in the diagnosis of cavernous autonomic neuropathy 
and cavernous smooth muscle dysfunction.5,6 
Because recording of cavernous smooth muscle electromyograms seemed to be a 
useful addition to the diagnostic evaluation of erectile dysfunction, we recorded 
penis-EMG's in 40 patients with erectile dysfunction of unknown etiology. 
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Patients and Methods 
For analysis of the diagnostic merits of penile electromyography we applied this 
technique in 40 randomly selected patients who sought out urologica] help because 
of complaints of erectile dysfunction. The investigation was incorporated in the 
diagnostic work up, that consists of history taking, physical and laboratory 
examinations, color duplex ultrasonography and neuro-urophysiological tests. 
A combination of needle electrode- and surface electrode EMG was measured in a 
room with a constant temperature of 25 0C. After preparation of the penile skin 
with alcohol a mono-polar concentric needle electrode (Dantec) was inserted in the 
left cavernous body. No anaesthetic was used. Following preparation of the penile 
skin with an abrasive in order to diminish skin resistance below 1.5 kn, two AgCl-
electrodes were attached on the dorsal surface of the right cavernous body. For 
recording of penis-EMG a customer designed neurophysiological apparatus was used 
(Nicolet Pathfinder) with two independent pre-amplifier and amplifier circuits 
allowing for independent parallel registration of two EMG-signals. For both channels 
sensitivity varied from 50 to 400 μΥ with a low band pass filter setting of 0.5 Hz 
and a high band pass filter setting of 100 Hz. The penis-EMG's were visualized on 
an on-line monitor screen and plotted on a 6-channel Allcoscript Gould-plotter with 
a paper speed of 1 mm/s. 
After application of the electrodes the investigator left the room for 20 minutes to 
allow the patient to relax and to let the insertion potentials fade out. Then 15 
minutes of recording of 'rest-potentials' was done. Pharmaco-audio-visual sexual 
stimulation (pharmaco/AVSS) was done with injection of 25 mg papaverine 
hydrochloride into the cavernous body and an erotic video tape was played; 
pharmaco/AVSS was followed by another 15 minutes of penis-EMG recording. 
Before removal of the needles, the erectile response was evaluated by inspection 
and palpation. 
For analysis, pre- and post-pharmaco/AVSS registrations as well as left- and right-
side recordings were compared. In some patients on-line intracavernous pressure 
was recorded. In others skin potentials measured with surface electrodes attached to 
the skin overlying the tibial shaft of the right leg were compared with simultaneously 
recorded penis-EMG's. 
Results 
Technical conductance of the tests was easy, although it proved to be time 
consuming. A serious restraint certainly was the complexity and amount of 
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equipment involved. Introduction of the needle electrode caused minimal discomfort 
to the patients. In 1 patient a long term complication was seen in the sense of an 
intracavernous abscess, that drained spontaneously. 
In some patients we indeed found some intermittent firing activity; however, we 
were not able to demonstrate any relation between this electrical activity and the 
penile state of erection. In none of the 40 patients we were able to reproduce the 
results of the aforementioned authors: no decrease of intracavernous electrical 
activity could be noticed after pharmaco/AVSS, nor did we find any specific 
potential characteristics. 
Our findings will be demonstrated by showing the most characteristic registrations in 
10 of the 40 patients. 
Figure 1 shows a penis-EMG measured with a concentric needle electrode. Pre-
pharmaco/AVSS shows baseline intermittent firing activity (upper graph). Post-
stimulus clinical examination revealed excellent penile tumescence and rigidity. The 
penis-EMG, however, shows an increase of electrical activity (lower graph). 
Figure 1: Pre- and post-pharmacolA VSS penb-EMG 
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Figure 2 shows a comparison of penis-EMG's recorded simultaneously with a 
concentric needle electrode (upper tracing) and two surface electrodes (lower 
tracing). After pharmaco/AVSS good penile tumescence and rigidity was palpated. 
Apart from artifacts induced by coughing (marked with *), no electrical activity was 
registered in either tracing. No differences were seen between pre- and post 
pharmaco/AVSS penis-EMG's. 
Figure 2: Comparison of penis EMG's recorded with concentric needle electrode 
and surface electrodes 
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Figures 3a and 3b demonstrate simultaneous registration of intracavernous pressure 
(upper tracing), and recordings with intracavernous needle electrode (middle tracing) 
as well as surface electrodes (lower tracing) shortly before and after 
pharmaco/AVSS. Intracavernous pressure rise shows adequate reaction to the 
stimulation. Clinical examination showed good tumescence and rigidity. The needle-
EMG shows electrical activity (bursts) at the moment of increasing intracavernous 
pressure. Hence, at the moment of relaxation of cavernous smooth muscle cells an 
increment of intracavernous electrical activity is noted (marked with *). Penile skin 
potentials measured with surface electrodes show a sudden increase after stimulation 
(marked with **). Furthermore, this figure demonstrates the high susceptibility of 
the recorded electrical signals to artifacts such as coughing. At the moment of 
intracavernous pressure rise due to coughing (marked with ***) a clear increment of 
electrical activity is noticed intra- as well as extracavernously. 
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Figure 3a: Regùtration of intracavemous pressure and penà-EMG's 
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Figure 3b: Registration of intracavemous pressure and penis-EMG's 
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Figure 4a shows a pre-pharmaco/AVSS registration of intracavemous pressure 
(upper tracing), and penis-EMG recordings with concentric needle electrode (middle 
tracing) and surface electrodes (lower tracing) attached to the leg. Notice typical 
pre-pharmaco/AVSS "bursts" of electrical activity in the recording with the 
concentric needle electrode, and the absence of such in the recording with surface 
electrodes. Figure 4b shows the post-pharmaco/AVSS registration in the same 
patient. No intracavemous pressure rise is seen. On clinical examination no 
tumescence and rigidity were palpated. Nevertheless, the pre-stimulus bursts have 
ceased. Notice the increase of skin potentials of the right leg measured with surface 
electrodes at the moment of starting the pharmaco/AVSS. 
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Figure 4a: Pre-pharmacolA VSS registration of intracavernous pressure, penis-EMG, 
and skin potentials of the right leg 
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Figure 4b: Post-pharmaco/A VSS registration of intracavernous pressure, penis-
EMG, and skin potentials of the right leg 
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Figure 5 shows a post-pharmaco/AVSS registration in a patient with good 
tumescence and rigidity. The recording shows penis-EMG with concentric needle 
electrode (upper tracing), and surface electrodes (lower tracing). In spite of good 
relaxation of cavernosa! smooth muscle cells proved by the good erectile response, 
there is no diminution of penile-EMG activity. Notice absence of correlation 
between the electrical activity measured intracavernous needle electrode and penile 
surface electrodes. 
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Figure 5: Post-pharmaco/AVSS penis-EMG with concentric needle electrode and 
surface electrodes 
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Figure 6 shows a recording of pre-pharmaco/AVSS penis-EMG with concentric 
needle electrode (lower tracing), and surface electrodes (upper tracing) at a high 
paper speed of 10 mm/sec. No relation between the electrical activity measured by 
intracavernous needle electrode and penile surface electrodes is found. 
Figure 6: Pre-pharmaco/AVSS penb-EMG with surface and needle electrodes 
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The upper graph in figure 7 shows a pre-pharmaco/AVSS registration with surface 
electrodes (upper tracing), and concentric needle electrode (lower tracing), whereas 
the lower graph demonstrates a post-pharmaco/AVSS registration in the same 
patient. Notice the marked increase of intracavernous electric activity measured with 
the needle electrode after pharmaco/AVSS (lower tracing). The artifact in the lower 
graph is caused by coughing (marked with *). During the entire measurement the 
surface electrodes measure an electric sweep with a frequency of approximately 60 
Hz. At that time the patients' pulse frequency was 60 beats per minute. 
Figure 7: Pre-pharmacolA VSS penb-EMG with surface and needle electrodes 
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The upper graph in figure 8 shows a pre-pharmaco/AVSS registration with 
concentric needle electrode (upper tracing), and surface electrodes (lower tracing). 
Notice the absence of any electrical activity on either trace. After pharmaco/AVSS 
the patient showed good tumescence and rigidity. Notice the typical "burst" on the 
upper tracing of the lower post-stimulus graph at the time of cavernous smooth 
muscle relaxation and the marked increase of penile skin potentials on the lower 
tracing. 
Figure 8: Pre- and post-pharmaco/AVSS registration of penis-EMG with 
concentric needle and surface electrodes 
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To eliminate the influence of the skin as a reference electrode as is obviously the 
case in surface electrodes, but also in concentric needle electrodes, we introduced 
two mono-polar needle electrodes with a conductive point and an insulated shan at 
a distance of 5 mm into one cavernous body and compared the electrical 
measurements with those obtained with a concentric needle electrode. Such a 
recording is shown in figure 9. The recording with the concentric needle electrode is 
shown in the upper tracing. Notice the presence of pre-pharmaco/AVSS firing 
activity in the upper tracing and the absence of such activity in the lower tracing. 
Remarkable is the absence of any correlation between the two post-pharmaco/AVSS 
penis-EMG's measured with a concentric needle electrode or two mono-polar intra-
cavernous needle electrodes. 
Figure 9 Pre- and postlpharmacolA VSS penb-EMG measured with a concentric 
needle electrode and two mono-polar needle electrodes 
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Finally, figure 10 shows a post-pharmaco/AVSS penis-EMG recording with a 
concentric needle electrode (upper tracing). This is compared with a recording of 
skin potentials of the right leg with two surface electrodes (lower tracing). Notice 
the coincidence of occurrence and the similarity of potential changes in both 
tracings. 
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Figure 10 Posl-pharmaco/AVSS registration of penü-EMG and skin potentials of 
the right leg 
I 
I 
ΘΟμν L -
30 sec ι 
"f· 
Discussion 
Although a technique for the evaluation of autonomic motor innervation of the 
penile corpora cavernosa by means of registration of electromyographical activity of 
the cavernous smooth muscle cells seems most promising and valuable, this study 
suggests that there still are some questions about the validity of the method as 
proposed by Gerstenberg and Stief.** As we have shown in this study it is feasible 
to measure penile electrical activity, but it remains questionable whether this is 
physiological activity related to the erectile mechanism or artificially induced 
potential changes. 
We indeed have found some basic intermittent firing activity as reported by 
Gerstenberg, but we were not able to relate this to the flaccid state of the penis 
(figures 3 and 8). Furthermore, we have found that the measurements of penis-
EMG are highly susceptible to artifacts induced by intracavernous pressure rise or 
movement at the moment of coughing (figures 2, 3 and 7). Most certainly this is 
due to the strong amplification that was needed to detect any signal. It is known 
from somatosensoiy evoked potential studies that at amplifier sensitivity settings of 
500 д or less even eye-movements can influence the outcome of the measurement 
in a negative sense. 
In contrast to what has been suggested by others7, we were not able to find any 
relationship between intracavernous electric activity measured by needle electrodes 
and such potentials measured by surface electrodes (figures 3, S, 6, 7 and 8). With 
surface electrodes attached to the right lower leg we found an increase of skin 
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potentials at the moment of pharmaco/audio-visual-sexual stimulation. This 
phenomenon that probably is due to an increment of sweating due to changing of 
the sympathie tonus of the skin vessels was similarly found on the penile skin 
(compare figures 3, 7 and 8 with figure 4b). The fact that the penile skin is prone 
to substantial electrical potential changes means that any electrode that uses the 
skin as reference electrode, as is the case for concentric needle electrodes, is 
unfitted for analysis of intracavernous electrical activity. In one patient we actually 
measured the same potentials intracavernously and on the leg (see figure 10). 
Bi-polar concentric needle electrodes or 2 mono-polar needle electrodes with an 
insulated shaft should overcome the problem of having the skin as a reference 
electrode. Whether these electrodes reflect intracavernous electrical activity more 
correctly remains unclear. In any case, there is a poor relationship between the 
penis-EMG measured by mono-polar electrodes and concentric needle electrodes, as 
is shown in figure 9. 
Conclusion 
The idea of measuring electrical activity of cavernous smooth muscle in order to 
evaluate autonomic motor neuropathy as a cause for erectile dysfunction is 
physiologically sound. However, for the moment there seems to be reason to cast 
some doubt upon the value of penile electromyography. Further research seems 
necessary to overcome the problems we have encountered, and to make this 
promising technique accessible for use on a routine basis. 
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Neurological disease is often associated with dysfunctions of the urogenital tract, and 
vice versa. Patients suffering from neurological disease (for example multiple 
sclerosis) or from metabolic disease causing neuropathy (for example diabetes 
mellitus) often visit their physicians because of problems with storage or evacuation 
of urine. Besides voiding dysfunctions, male patients suffering from such diseases 
often complain of erectile dysfunction. 
Our ideas concerning occurrence and cause of urinary and erectile problems in 
patients with neurological disease have undergone important changes. Until recently 
it was thought that any urogenital tract dysfunction in a patient with a neurological 
disease was caused by that disease. Besides that, it was assumed that patients, who 
did not suffer from any know neurological disease, impossibly could suffer from 
neurogenic urogenital tract dysfunction. 
Introduction of neuro-urophysiological investigatory techniques as described in this 
thesis have changes our understanding of the relation between neurology and 
urology considerably. These neuro-urophysiological investigations, that yield objective 
information about the intactness of urogenital neural tracts, have not only appeared 
to be normal in some patients with clear neurological disease, sometimes they have 
proved to be abnormal in unsuspected patients. 
In chapter 1 a brief historical overview is given. Techniques that formed the basis of 
our neuro-urophysiological investigations (NUPHI), such as somatosensory evoked 
potential measurements and electromyography are addressed. From this overview it 
becomes clear that application of these techniques in clinical urology dates from no 
earlier than the 1970s. In chapter 1.3 an overview of the relevant neuro-anatomical 
pathways is given. Distinction is made between autonomic and somatic neural 
pathways. The former are mainly involved with bladder and penis function, the 
latter primarily deal with sphincter physiology. In chapter 1.4 technical aspects of 
the neuro-urophysiological investigations are discussed. These investigations consist 
of the measurement of two somatosensory evoked potentials: tibial evoked potential 
(ТЕР) and pudendal evoked potential (PEP). Furthermore, two sacral reflex 
latencies are determined: bulbocavernosus reflex (BCR) and urethro-anal reflex 
(UAR). The various neuro-anatomical pathways and neuro-urophysiological 
measurements are depicted in figure 2, chapter 1. 
In chapter 2 an overview is given of the literature involved with neurophysiological 
measurements and techniques applied in urology. From this it becomes clear that 
these techniques have not yet found a widespread application. The number of 
publications is small and represents advocates as well as opponents. 
The latter fact has lead to the aim of this thesis as forwarded in chapter 3. The aim 
of this thesis is applying a well standardised investigatory method (NUPHI) in 
selected and defined patients and by doing so trying to define the merits of this 
method. It also tries to analyze the possibilities and limitations of such neuro-
urophysiological investigations for clinical urological practice. Because the neuro-
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urophysiological investigations mainly deal with somatosensory neural tracts we also 
analyzed and developed new techniques that deal with autonomic motor nerve 
function. The latter is of course of great importance because urogenital 
neurophysiology mainly deals with autonomic motor nerves. 
In chapter 4 results are reported of comprehensive urodynamical and neuro-
urophysiological investigations of 40 patients with recent onset multiple sclerosis 
(MS). These investigations revealed important findings for the diagnostic and 
therapeutic assessment of multiple sclerosis patients. Patients without complaints of 
lower urinary tract dysfunction had important urodynamic abnormalities. Apparently, 
patient history is unsuited for the clinical assessment. Therefore, physicians must 
base their therapies on objective neurourodynamical information. Also the finding of 
many neurourodynamical abnormalities in patients with a short duration of disease 
was striking. As proved by our neuro-urophysiological investigations multiple 
sclerosis has great impact on urogenital tract function, even in an early stage of the 
disease. It is, therefore, concluded in this chapter that early diagnosis and treatment 
is indicated in multiple sclerosis patients, regardless the presence or absence of 
urological symptoms. 
Chapter 5 shows that subclinical neurological abnormalities can exist in patients with 
complaints of erectile dysfunction and no overt neurological disease. Subtle penile 
sensory disorders become more and more important in the ageing impotent male. 
This chapter concludes that erectile dysfunction in the elderly male can be 
attributed to decreasing sensibility of the penis (sensory deficit impotence). 
In chapters 6 and 7 the neuro-urophysiological investigations are applied on 
impotent patients with diabetes mellitus. Comparing the results with those obtained 
in non-diabetics allowed determination of the neuro-pathophysiological substrate of 
diabetic impotence. Chapter 6 shows that of the possible causes for erectile 
dysfunction in diabetic patients (neuropathy, vasculopathy and hormonal 
disturbances) the neuropathy is of overriding importance in the etiology of diabetic 
erectile dysfunction. This chapter also shows that there is a relationship between 
improper diabetes regulation and the occurrence of impotence in these patients. In 
chapter 7 the impact of neurological and vascular factors on the etiology of diabetic 
impotence is further analyzed. Therefore, the neuro-urophysiological investigations 
are compared with the results of color duplex ultrasonography of penile arteries and 
veins. Again the neurological abnormalities emerge as most important. A remarkable 
finding of this study was that in contrast to what has been reported in the literature 
in respect to the cause of vasculogenic impotence in diabetics, affliction of penile 
arteries is of lesser importance than is dysfunction of the veno-occlusive mechanism. 
Chapter 8 reports on a new technique for the investigation of motor innervation of 
the urinary bladder. Development of such a method seemed necessary because 
current investigatory techniques investigated sensory tracts only. This method consists 
of magnetic stimulation of motor nerves in the cauda equina and measurement of 
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the electromyographical signal in the bladder and pelvic floor muscles. Thus, 
autonomic and somatic nerves can be investigated separately. The study shows that 
our method yields reproducible and clearly interpretable results. It also shows that 
motor nerve conduction to the bladder is much slower than to the pelvic floor 
muscles. The latter finding corroborates our knowledge of urogenital 
neurophysiology. 
Finally, chapter 9 is a critical appraisal of a currently introduced technique of penile 
electromyography ('penis-EMG'). This penis-EMG consists of measurement of the 
spontaneous electrical activity of the smooth muscle cells in the corpora cavernosa 
of the male. This electrical activity is attributed to physiological changes in the tone 
of the smooth musculature of the corpora cavernosa. Some authors have claimed 
characteristic changes of the penis-EMG from the moment of penile flaccidity to 
rigidity. Unfortunately, we were not able to reproduce these results. Our 
investigations suggest that penile electromyography is merely a registration of 'bias' 
than of physiological events. Chapter 9 concludes that the idea of penile 
electromyography is physiologically sound and deserves our closest attention, because 
such a technique would open an interesting field for further research. For the 
moment, however, the results should be encountered with some restraint. 
Future perspectives 
It might have become clear that the findings of our neuro-urophysiological 
investigations are at the same time interesting and important. The neuro-
urophysiological investigations allow objective analysis of possible involvement of 
neurourological tracts in dysfunction of the urogenital tract. It seems helpful in 
differentiating between psychogenic and organogenic disease. The latter is rather 
complicated, especially in patients with complaints of erectile dysfunction. 
Furthermore, these neuro-urophysiological investigations enable the clinician to 
analyze whether a urological dysfunction in a patient with a known neurological 
disease should be attributed to that disease. This has great impact on therapeutical 
decision making in clinical practice. 
The findings of our investigations increase our understanding of the underlying 
pathophysiological mechanisms of urogenital tract dysfunction. Even subclinical 
abnormalities that would have remained hidden from the clinicians' eye can be 
discovered. And because these investigations yield information on autonomic and 
somatic nerve function a comprehensive analysis of (dys)functions of the urogenital 
tract has now become possible. 
Because these interesting and useful neuro-urophysiological investigations require 
minimal logistic conditions, it can be expected that they will gain a more widespread 
application. 
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Neurologische ziekten worden vaak in verband gebracht met het dysfunctioneren van 
de urogenitale tractus en vice versa. Patienten, die aan een neurologische ziekte 
lijden (bijvoorbeeld multiple sclerose) of die een stofwisselingsziekte hebben welke 
zenuwaandoeningen kan veroorzaken (bijvoorbeeld suikerziekte), bezoeken vaak hun 
arts in verband met problemen met het ophouden of juist lozen van de urine. 
Mannelijke patiënten met deze ziekten hebben daarnaast vaak te kampen met 
potentiestoornissen: de zgn. erectiele dysfunctie. 
Onze ideeën omtrent oorzaak en voorkomen van plas- en potentieproblemen bij 
patiënten met een neurologisch ziektebeeld zijn de laatste jaren aan sterke 
veranderingen onderhevig geweest. Tot voor kort gold dat elk probleem betreffende 
de urogenitale tractus bij patiënten met een neurologische ziekte door deze 
neurologische ziekte veroorzaakt werd. Daarnaast was men ervan overtuigd dat 
patiënten, die niet leden aan een van de bekende neurologische- of 
stofwisselingsziekten, onmogelijk urogenitale dysfunctie ten gevolge van neurologisch 
feilen konden hebben. 
Introductie van neuro-urofysiologische onderzoektechnieken zoals beschreven in dit 
proefschrift hebben het bovengenoemde gedachtengoed ingrijpend gewijzigd, omdat 
zij slechts ten dele bevestigden wat voorheen als vaststaand aangenomen werd. Deze 
neuro-fysiologische onderzoeken, welke objectieve informatie verschaffen over het 
intact zijn van de zenuwbanen van de urogenitale tractus, blijken niet alleen 
normaal te zijn bij sommige patiënten met duidelijk neurologisch ziektebeeld, zij zijn 
soms afwijkend bij patiënten, die in het geheel niet verdacht worden van een 
neurologisch lijden. Deze bevindingen bevestigen derhalve het belang van deze 
objectieve onderzoeken ter correctie van een vooringenomen klinisch denkbeeld. 
In hoofdstuk 1 wordt een kort overzicht gegeven van de geschiedenis van de 
neurofysiologische meetmethoden, welke ten grondslag liggen aan het neuro-
urofysiologisch onderzoek (NUFO). Met name worden besproken de ontwikkelingen 
welke geleid hebben tot de registratie van electrische spieractiviteit 
(electromyografie) en van hersenreacties na het stimuleren van sensibele perifere 
zenuwbanen (somatosensorische evoked potentials). Uit het historisch overzicht blijkt 
dat deze technieken pas in het begin van de zeventiger jaren hun intrede hebben 
gedaan in de urologie. 
Aangezien het neuro-urofysiologisch onderzoek een uitspraak moet doen over het al 
dan niet intact zijn van zenuwbanen, die de werking van blaas en geslachtsorganen 
besturen, worden in hoofdstuk 1.3 de belangrijkste neuro-anatomische banen 
besproken. Hierbij wordt onderscheid gemaakt tussen enerzijds autonome 
zenuwbanen, die met name blaas en penis innerveren, en anderzijds somatische 
zenuwbanen welke vooral de sluitspieren besturen. In hoofdstuk 1.4 worden de 
technische aspecten van het neuro-urofysiologisch onderzoek besproken. Het bestaat 
uit de meting van twee somatosensorische evoked potentials, te weten de tibialis 
evoked potential (ТЕР) en de pudendus evoked potential (PEP). Verder worden 
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twee sacrale reflex latentietijden gemeten, de bulbocavernosus reflex (BCR) en de 
urethro-anale reflex (UAR). De verschillende neuro-anatomische banen en de 
neuro-urofysiologische metingen zijn weergegeven in figuur 2, hoofdstuk 1. 
In hoofdstuk 2 wordt een overzicht gegeven van de literatuur met betrekking tot 
neurofysiologische meetmethoden toegepast in de urologie. Hierbij valt met name 
op dat de neuro-urofysiologische meettechniek vooralsnog een geringe bekendheid 
geniet. Publicaties zijn gering in aantal en vertegenwoordigen zowel voor- als 
tegenstanders. 
Dit heeft dan ook geleid tot de doelstelling van dit proefschrift zoals weergegeven in 
hoofdstuk 3. Dit proefschrift beoogt door het toepassen van een gestandaardiseerde 
onderzoektechniek (neuro-urofysiologisch onderzoek) bij groepen goed gedefinieerde 
en geselecteerde patiënten de mogelijkheden zowel als de onmogelijkheden van de 
techniek na te gaan. Voorts wordt getracht het belang van de neuro-urofysiologisch 
onderzoek bevindingen voor de alledaagse praktijk te analyseren. Omdat het neuro-
urofysiologisch onderzoek vooral sensibele zenuwbanen onderzoekt en daardoor het 
motorisch deel van het autonome zenuwstelsel, dat van groot belang is bij het goed 
functioneren van blaas en geslachtsorganen, niet tot zijn onderzoeksterrein heeft, 
worden technieken welke deze hiaten wellicht kunnen opvullen nader bekeken. 
In hoofdstuk 4 wordt gerapporteerd over uitgebreid urodynamisch en neuro-
urofysiologisch onderzoek bij 40 patiënten bij wie recent de diagnose 'multiple 
sclerose' (MS) gesteld werd. Dit onderzoek bracht meerdere voor diagnostiek en 
behandeling van deze patiënten belangrijke bevindingen aan het licht. Zo bleken er 
belangrijke urodynamische afwijkingen te bestaan bij patiënten, die in het geheel 
geen klachten hadden over hun urogenitale tractus Blijkbaar is het klachtenpatroon 
van multiple sclerose patiënten een slechte leidraad voor de arts. Deze laatste zal 
daarom zijn behandelingsplan steeds moeten laten afhangen van de objectieve 
neuro-urologische bevindingen. Verder viel het grote aantal urologische afwijkingen 
op bij deze patiënten, die slechts kort aan multiple sclerose leden. Zoals met het 
neuro-urofysiologisch onderzoek aangetoond kon worden heeft multiple sclerose 
reeds in een vroeg stadium van de ziekte belangrijke consequenties voor het 
functioneren van de urogenitale tractus. De slotconclusie van dit hoofdstuk is dat 
vroege diagnostiek en behandeling door de uroloog noodzakelijk is bij elke multiple 
sclerose patient, ongeacht de aan- of afwezigheid van urologische klachten. 
Hoofdstuk 5 laat zien dat verborgen neurologische afwijkingen kunnen bestaan bij 
mannen met erectiestoornissen zonder duidelijke neurologische ziekte. Deze subtiele 
stoornissen aan de gevoelszenuwen van de geslachtsorganen nemen in belangrijkheid 
toe naarmate de patiënten ouder zijn De conclusie van dit hoofdstuk is dat 
erectiele dysfunctie bij de ouder wordende man frequent en in belangrijke mate 
veroorzaakt wordt door het afnemen van de gevoeligheid van het geslachtsorgaan 
(sensory deficit impotence). 
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In hoofdstukken 6 en 7 wordt het neuro-urofysiologisch onderzoek toegepast bij 
patiënten met diabetes mellitus (suikerziekte) en erectiestoornissen. Door de 
resultaten te vergelijken met die, welke bij niet-diabeten werden verkregen, kon het 
neurologisch substraat voor de diabetische impotentie vastgelegd worden. Uit het 
onderzoek, dat in hoofdstuk 6 beschreven wordt, blijkt dat wanneer men de 
verschillende mogelijke oorzaken voor erectiestoornissen bij diabetici naast elkaar 
legt (te weten: neurologische afwijkingen, bloedvatproblematiek en 
hormoontekorten) de afwijkingen aan de zenuwbanen een doorslaggevende rol 
spelen. Ook toont dit onderzoek aan dat een slechte diabetes regulatie in verband 
staat met het voorkomen van diabetische impotentie. In hoofdstuk 7 wordt de 
relatie tussen vasculaire en neurologische parameters bij impotente mannen met 
suikerziekte nog verder geanalyseerd door het neuro-urofysiologisch onderzoek te 
vergelijken met de uitkomsten verkregen door kleuren-duplex echografie van de 
penis arteriën en venen. Opnieuw blijkt dat de neurologische afwijkingen bij deze 
impotente diabeten de belangrijkste rol spelen bij het ontstaan van impotentie. Een 
opmerkelijke bevinding was dat, in tegenstelling tot eerder gepubliceerde gegevens, 
aantasting van de aanvoerende bloedvaten (arteriën) van de penis nauwelijks enige 
rol leek te spelen. 
In hoofdstuk 8 wordt een nieuwe techniek gepresenteerd voor het onderzoeken van 
de motorische bezenuwing van de blaas. Het motief voor het ontwikkelen van deze 
techniek ligt in het feit dat de voorhanden zijnde meetmethoden zich met name 
concentreren op de sensibele blaasinnervatie. Aangezien de urogenitale tractus voor 
het goed functioneren in grote mate afhankelijk is van motorische zenuwbanen is 
het belang van deze nieuwe onderzoektechniek evident. De methode, die beschreven 
wordt bestaat uit het magnetisch stimuleren van de motorische zenuwvezels in de 
cauda equina en het afleiden van een electromyografisch signaal in zowel blaas als 
bekkenbodem. Op deze wijze kunnen separaat autonome en somatische motorische 
vezels onderzocht worden. Uit deze studie blijkt dat de techniek goed 
interpreteerbare en reproduceerbare resultaten oplevert. Ook blijkt, conform aan 
hetgeen uit de neuro-anatomie bekend is, dat de zenuwgeleiding naar de blaas 
trager verloopt dan naar de bekkenbodem. 
In hoofdstuk 9 wordt tenslotte een kritische evaluatie gegeven van een andere 
techniek die recent geïntroduceerd is met als doel meer informatie te verschaffen 
over de motorische innervatie van de urogenitale tractus. Deze 'penis-
electromyografie' (penis-EMG) bestaat uit het registreren van spontaan optredende 
electrische fenomenen in het zweilichaam van de penis van de man. Deze 
electrísche veranderingen zouden veroorzaakt worden door aanspannen of 
verslappen van de gladde spiercellen in de corpora cavernosa. Andere auteurs 
hebben karakteristieke veranderingen in dit penis-EMG beschreven bij het ontstaan 
van een erectie. Helaas bleek de techniek in onze handen niet de eerder beschreven 
resultaten op te leveren. Ons onderzoek leek aan te tonen dat het bij de penis-
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electromyografie eerder gaat om het registreren van 'ruis' dan om het meten van 
fysiologische signalen. De conclusie van hoofdstuk 9 luidt dat het penis-EMG 
vanwege de achterliggende fysiologische gedachte zeer zeker verdere aandacht 
verdient. De klinische mogelijkheden van zulk een eenvoudige meetmethode zouden 
zeker groot zijn. Voor het moment echter moet enige terughoudendheid betracht 
worden met betrekking tot de waarde van dit onderzoek. 
Toekomstverwachtingen 
Zoals uit het bovenstaande moge blijken zijn de bevindingen van het neuro-
urofysiologisch onderzoek toegepast bij patiënten met problemen van het 
dysfunctioneren van de urogenitale tractus tegelijk belangrijk en interessant geweest. 
Het neuro-urofysiologisch onderzoek biedt de mogelijkheid bij verschillende 
ziektebeelden en klachtenpatronen een objectief beeld te krijgen over een eventueel 
onderliggend neurologisch lijden. Het kan helpen differentiëren tussen psychogeen 
en organisch lijden, wat zonder deze techniek bij bijvoorbeeld patiënten met 
erectiestoornissen zeer moeilijk is. Verder schept het neuro-urofysiologisch 
onderzoek de mogelijkheid te analyseren of een bepaalde urologische functiestoornis 
bij patiënten met een neurologische ziekte ook daadwerkelijk door het neurologisch 
lijden veroorzaakt wordt. Voor de medicus practicus zal dit van groot belang zijn bij 
het bepalen van een therapeutisch plan. 
De bevindingen vergroten ons inzicht in het ontstaan van functiestoornissen van de 
urogenitale tractus. Het neuro-urofysiologisch onderzoek stelt ons immers instaat om 
objectief voor het oog onzichtbare (subklinische) afwijkingen vast te stellen. Door 
het feit dat in het neuro-urofysiologisch onderzoek meetmethoden verenigd zijn, die 
zowel het autonome als het somatische zenuwstelsel onderzoeken kan het aandeel 
van beide in de genese van dysfunctie van de urogenitale tractus geanalyseerd 
worden. 
Omdat het hier een onderzoeksmethode betreft, die qua technische en personele 
voorwaarden niet meer vereist dan momenteel voorhanden is in urologische centra 
waar urodynamisch onderzoek verricht wordt, mag verwacht worden dat het neuro-
urofysiologisch onderzoek in de toekomst meer en meer toegepast zal worden. 
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